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Zusammenfassung 5
Zusammenfassung
Die Magnetresonanzspektroskopie (MRS) hat sich während der letzten 
Jahrzehnte zu einer wertvollen Methode für die Untersuchung physiologischer 
Prozesse im menschlichen Körper entwickelt. Sie erlaubt den Einblick in den 
Metabolismus verschiedener Organe und wird oft als komplementäre 
Diagnosemethode für Stoffwechselveränderungen eingesetzt, die durch 
bestimmte Krankheiten wie Krebs oder multiple Sklerose entstehen. Die 
Konzentrationen der Metaboliten reflektieren dabei Aspekte der Physiologie 
und der Biochemie und sind von fundamentalem Interesse sowohl für die 
Wissenschaft als auch für eine genauere klinische Diagnose von Krankheiten. 
Durch den Einsatz höherer Feldstärken an den Magnetresonanztomografie-
Geräten (MRT) konnten das Signal-zu-Rausch-Verhältnis sowie die spektrale 
Auflösung kontinuierlich erhöht werden. Trotzdem sind noch einige technische 
Hürden zu überwinden, um das umfassende Potential der Technik für die 
wissenschaftliche Forschung und die routinemässige klinische Anwendung der 
MRS voll auszuschöpfen. So behindern oft Blutfluss, Suszeptibilitäts-
Unterschiede zwischen den verschiedenen Gewebetypen und der im Vergleich 
zu den tiefen Metabolitenkonzentrationen hohe Wassergehalt die Akquisition 
guter Spektren. Zudem sind heutige Methoden zur quantitativen Bestimmung 
von Metabolitenkonzentrationen aufwändig oder ungenau. Während 
Konzentrationsverhältnisse zwischen Metaboliten oft zuverlässig bestimmt 
werden können (sogenannte „relative“ Quantifizierung), ist es schwierig, die 
millimolaren Konzentrationen der Metaboliten zu bestimmen („absolute“ 
Quantifizierung). Verschiedene Quantifizierungsmethoden mit separaten 
Referenzstandards („externe Referenz“) oder unter Annahme einer konstanten
Wasser- oder Metabolitenkonzentration innerhalb des Gewebes („interne 
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Referenz“) wurden entwickelt. Externe Referenzen haben jedoch den Nachteil, 
dass sie für jede Untersuchung zusätzliche Messungen erfordern, während bei 
internen Referenzen die Konzentration des Referenz-Metaboliten durch
physiologische Vorgänge oder Krankheit verändert sein kann.
Mittels funktioneller MRS können Zeitverläufe von physiologischen 
Parametern, von Metabolitenkonzentrationen und des pH-Wertes in Ruhe und 
während Aktivierung gemessen werden. So ist es beispielsweise möglich, die 
Veränderungen der am Muskel-Stoffwechsel beteiligten Metaboliten während 
der Muskelkontraktion zu verfolgen. Zusätzlich zur Quantifizierung der 
Metabolitenkonzentrationen ist bei solch dynamischen Spektroskopie-
Messungen jedoch eine zuverlässige Normierung der Belastung des Muskels 
nötig, um eine Standardisierung unter Probanden oder Patienten zu erreichen. 
Diese kann durch die Messung der individuellen Maximalkraft und eine darauf 
angepasste Belastung während der Spektroskopie-Messung erfolgen.
Das Ziel der vorliegenden Dissertation war die Entwicklung von Methoden zur 
zuverlässigen Quantifizierung von Metabolitenkonzentrationen in Ruhe und 
unter normierter Belastung. Die Quantifizierung sollte für physiologische und 
klinische Studien an verschiedenen Kernen einfach anzuwenden und wenig 
zeitintensiv sein. 
Quantifizierung von Metabolitenkonzentrationen. Für die Quantifizierung 
millimolarer Metabolitenkonzentrationen wurde ein Verfahren aus der NMR-
Spektroskopie (ERETIC, Electric REference To access In vivo 
Concentrations) auf die Bedingungen in der in vivo-Spektroskopie angepasst. 
Bei dieser Methode kommt ein elektronisches Kalibrationssignal zur 
Quantifizierung der Spektren zum Einsatz. Durch eine kleine Kalibrationsspule
wird dieses zuvor mittels eines Präzisionsphantoms kalibrierte Referenzsignal 
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eingespeist. Es erscheint im Spektrum anschliessend als zusätzlicher Peak. 
ERETIC wird während der Akquisition des Spektrums über einen zusätzlichen 
Breitband-Kanal des Magneten gesendet. Das Referenzsignal simuliert ein 
relaxierendes Spin-Signal mit vordefinierter Linienbreite, Phase, Amplitude 
und Frequenz. Um eine genaue Skalierung des Kalibrations- Signals mit den 
Metaboliten- Signalen zu erreichen, wird der Referenz-Puls induktiv in eine 
Sende- und Empfangsspule mit homogenem Feld (Volumenspule) gekoppelt. 
Eine optische Signaltransmission verhindert das Übertragen von Störsignalen, 
welche durch Sender oder elektrische Komponenten innerhalb des Scanner-
Raums auftreten können. Das entwickelte Setup ermöglicht die Quantifizierung 
von Metaboliten in Spektroskopie- Messungen mit verschiedenen Kernen ohne 
zusätzlichen Aufwand während der Untersuchung. Ein solches System soll in
Zukunft auch für klinische Anwendungen eingesetzt werden und damit eine 
zuverlässige Quantifizierung ermöglichen.
Quantifizierung von physiologischen Parametern während dynamischer 
Spektroskopie- Messungen im Muskel. Für die Bestimmung von 
Metabolitenkonzentrationen unter Belastung wurde ein Ergometer entwickelt, 
welches mittels Dynamometer die aufgebrachte Kraft des Wadenmuskels 
während isometrischer Kontraktion messen kann. Der Kraftwert während der 
Messung wird von einer für die funktionelle MRT entwickelten Software 
aufgezeichnet und dem Probanden via Projektor als visuelles Feedback 
angezeigt. Vor einer Messung kann jeweils die maximale Kraft des Probanden 
gemessen werden. Ein bestimmter Prozentsatz dieser Maximalkraft wird dem 
Probanden danach während der Muskelkontraktion als Zielwert vorgegeben 
und zusammen mit dem momentan erreichten Kraftwert auf eine Leinwand 
projiziert, während die Spektren gemessen werden. Um den Start der 
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Kraftmessung mit der Spektroskopiemessung zu synchronisieren war es 
notwendig, die Steuerungs-Software des Scanners zu modifizieren. Die 
Analyse und Quantifizierung der spektroskopischen Daten erfolgte 
anschliessend mit Hilfe einer speziell entwickelten Software auf Basis von IDL.
Das entwickelte Ergometer-Setup wurde in zwei metabolischen Studien 
erfolgreich eingesetzt. In diesen wurde das Verhalten des Muskelmetabolismus 
unter Belastung und in Ruhe untersucht. In einer ersten Studie wurde der 
Einfluss von ischämischem Krafttraining auf den untrainierten Muskel bei 
gesunden Probandinnen erforscht, während sich eine zweite Studie mit den 
Veränderungen von pH-Werten, Metabolitenkonzentrationen und 
Erholungskonstanten von phosphorhaltigen Metaboliten an Diabetikerinnen 
befasste. 
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Summary
Over the last decades, magnetic resonance spectroscopy (MRS) has become a 
valuable method for the assessment of physiologic processes in the human 
body. MRS provides an insight into the metabolism of different organs and is 
used as a complimentary method for the diagnosis of metabolic alterations that 
result from various diseases such as cancer and multiple sclerosis. The 
concentrations of the metabolites reflect aspects of physiology and 
biochemistry and are of fundamental interest for the assessment of scientific 
questions and for the diagnosis of diseases in clinics. 
The spectral resolution as well as the signal to noise ratio have continually
improved due to the availability of higher magnetic field strengths. Still, there 
are many technical issues to address in order to make use of the extensive 
potential of the MRS technique for scientific and routine clinical applications.
Blood flow, differences in susceptibility between different tissue types and a 
high water content compared to the low metabolite concentrations often impair 
the acquisition of high quality spectra. In addition, many methods that are 
available today for the determination of quantitative metabolite concentrations 
are either laborious or inaccurate. While concentration ratios of different 
metabolites can often be determined quite accurately (so-called „relative” 
quantification), it remains difficult to determine millimolar concentrations of 
the metabolites („absolute“ quantification). Several quantification methods that 
involve separate concentration standards („external reference“) or assume a
certain water or metabolite concentration within a tissue („internal reference“)
have been developed. A main disadvantage of external references is the need 
for an additional measurement for each examination. Using the internal 
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reference method, on the other hand, bears the risk of assuming wrong 
reference metabolite concentrations in the case of disease or when 
physiological changes have occurred. 
Using functional MRS, time courses of physiological parameters, metabolite 
concentrations and pH values can be followed at rest and under activation. For 
instance, it is possible to measure changes of metabolites that are involved in 
muscle metabolism during muscle contraction. In addition to the reliable 
quantification of metabolite concentrations in these measurements, it is 
necessary to achieve a normalization of the load that the muscle experiences, so 
that standardization among patients and volunteers can be attained. A possible 
approach is to measure the individual maximal voluntary contraction force and 
to subsequently adjust the load during the exercise according to this value.
The goal of this thesis was the development of spectroscopic methods for the 
reliable quantification of metabolite concentrations at rest and under 
normalized loading conditions. The quantification should be easy to apply and
minimally time-consuming so that it could be successfully applied in 
physiological and clinical settings.
Quantification of metabolite concentrations. For the millimolar
quantification of metabolite concentrations, a technique from nuclear magnetic 
resonance (NMR) spectroscopy (ERETIC, Electric REference To access In
vivo Concentrations) was adapted to the conditions encountered in clinical in 
vivo spectroscopy. The ERETIC method is based on the use of an electric 
calibration signal for spectral quantification. After pre-calibration with a 
phantom containing well-known concentrations of metabolites, the artificial 
reference signal is injected through a small calibration coil, and it then appears 
as an additional peak in the spectrum. ERETIC is emitted during the acquisition 
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of the spectra through a broadband channel of the MR system. The reference 
signal simulates a relaxing spin signal with a pre-defined line width, phase, 
amplitude and frequency. To achieve an accurate scaling of the reference signal 
with the metabolite signals, the reference signal was inductively coupled into a 
transmit/receive coil with a homogenous field (volume coil). An optical signal 
transmission line was built to inhibit the carriage of interfering signals, which 
may arise through radio transmitters and electronic devices in the scanner 
room. The developed ERETIC setup enables the quantification of metabolites 
in spectroscopic measurements with different nuclei. No additional 
measurements have been made during the MRS examination. In the future, 
such a system shall also be used in clinical settings to enable the reliable
quantification of metabolite concentrations.
Quantification of physiologic parameters during dynamic spectroscopy 
measurements in the muscle. For the determination of metabolite 
concentrations under load, an ergometer has been developed which measures 
the force that is exerted by the calf during isometric contractions by means of a 
dynamometer. The force that is exerted during the measurement is recorded by 
a software package that was developed for functional magnetic resonance 
imaging (fMRI). It is then displayed to the subject as a visual feedback via a 
projector. Before the spectroscopy measurement, the maximal voluntary 
contraction force against the pedal (MVFP) can be determined for each subject. 
During the acquisition of the spectroscopy scans, a certain percentage of the 
MVFP is then displayed to the subject on a screen as a target force, together 
with the currently exerted force. To synchronize the start of the spectroscopy 
measurement with the measurement of the exerted force, it was necessary to 
modify the controller software of the scanner. The analysis and quantification 
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of the spectroscopic data was subsequently performed using a custom-made
software on the basis of IDL.
The developed ergometer setup was successfully applied in two metabolic
studies, where the behavior of the muscle metabolism was assessed at rest and 
under exercise. In a first study, the influence of ischemic force training on the 
untrained muscle was investigated in healthy subjects. A second study was 
focused on changes of pH values, metabolite concentrations and recovery 
constants of phosphorus containing metabolites in diabetes patients.
Chapter 1: Absolute Quantification 13
Chapter 1:
QUANTIFICATION OF TISSUE 
METABOLITE LEVELS BY 1H MRS
14 Summary
1.1 Introduction
In vivo magnetic resonance spectroscopy methods have been available for more 
than three decades. They allow for a non-invasive assessment of tissue 
metabolite levels over time. Metabolites that contain hydrogen (1H), 
phosphorus (31P) and carbon (13C) atoms, as well as certain molecules 
containing other resonating nuclei such as fluorine (19F) can be observed. 
Depending on their chemical environment, i.e. the molecule in which they 
reside, these nuclei resonate at specific frequencies. Each metabolite then gives 
rise to distinct peaks in a magnetic resonance spectrum.
Theoretically, millimolar concentrations of these metabolites can be calculated 
from the peak area since all atoms of a kind induce exactly the same amount of 
measurable signal. However, many physical parameters, as well as tissue-
specific properties, are not known exactly.
Knowing the metabolite concentrations in tissues and being able to follow their
time courses is important for physiological studies as well as in clinical 
settings. Diseases and physiological processes can be assessed, and treatments 
can be monitored using such information. However, obtaining quantitative 
information from MRS is a challenge in that data acquisition times are 
generally long, the spectral resolution is limited and the signal to noise ratio 
(SNR) is low.
Nevertheless, different calibration strategies have been developed that allow for 
the quantification of an in vivo metabolite concentrations by comparing its peak 
area to the area of a reference standard of known concentration. 
One possibility is to acquire water spectra in a separate scan and reference them 
to the measured metabolite signals (Thulborn & Ackerman, 1983; Barker et al., 
1993). The water signal is then assigned a tissue-specific millimolar 
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concentration. This concentration is assumed to be constant for a specific tissue 
and absolute metabolite concentrations are estimated from the ratio of the water 
signal to the metabolite signal. Water has a very high SNR, so that only a few 
averages are needed to acquire a reference spectrum. 
Similarly, the concentration of any metabolite in the tissue, such as creatine 
(Frahm et al., 1989), can be assigned an average literature value that has been 
determined i.e. from tissue extracts. One has to assume that this literature value 
is similar in any subject and remains constant. The quantification techniques 
that rely on a signal that is present in the body are known as internal 
referencing methods.
Another quantification technique involves the measurement of an external 
reference standard with known metabolite concentrations. This reference 
standard is placed next to the subject or measured in a separate scan (Buchli et 
al., 1994; Murphy-Boesch et al., 1998). The measured metabolite areas are then
compared.
A third quantification method that has been widely applied is based on the 
reciprocity principle (Hoult & Richards, 1976; Hoult, 2000) and uses the 
voltage that is needed in order to obtain the maximal signal response for 
calibration (see (Kreis et al., 2001) and references in (Kreis, 1997)). Using this 
technique overall load on the coil - a value that depends on patient size and 
shape and leads to a more or less strong damping of the signal - can be 
compensated so equal metabolite signals can be obtained from different 
patients and phantoms. This method can be combined with the use of an 
external reference standard.
Most of the above quantification methods require additional measurements. In 
the case where a metabolite that is naturally present in the spectra is used to 
determine millimolar concentrations of the other metabolites, no additional 
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scan time is needed. However, one relies on the correct estimation of the 
reference metabolite concentrations. Many metabolite concentrations change 
under physiological conditions, e.g. with the age of the volunteer (Tofts, 2003)
or with physiological stress, and during the course of a disease (Helms, 2001; 
Laule et al., 2004). Depending on the tissue under investigation, no metabolite 
may be present that is qualified to serve as an internal reference. 
Recently, a quantification technique has been developed in nuclear magnetic 
resonance (NMR) that allows for the acquisition of reference signal and 
metabolite signals in a single scan and does not rely on assumptions about 
metabolite concentrations (Barantin, 1997).  It is based on the injection of an 
artificial synthetic reference signal (ERETIC, Electric REference To access In
vivo Concentrations) that mimics the properties of the spin signal. This 
synthetic reference is calibrated once and then appears as an additional peak in 
the spectrum. The ERETIC method has been successfully applied in many 
studies ex vivo for the determination of metabolite concentrations in tissue 
homogenates and solutions. For an effective in vivo application, however, many 
additional subject specific and hardware parameters have to be considered.
1.2 Objectives
The main objective of the first part of this thesis was the development of in 
vivo MRS hardware and software that allow for accurate and precise in vivo
quantification of tissue metabolite concentrations. More specifically, it was the 
aim to further develop the ERETIC quantification method so that accurate 
metabolite concentrations can be quantified in vivo without the need for an 
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additional measurement and with no discomfort for the subject. Moreover, the 
setting should be fully compatible with clinical settings. 
The ERETIC technique has been previously used for in vitro quantification of 
metabolites using a broad band antenna (Barantin, 1997; Akoka et al., 1999). In 
this publication, the antenna is attached to the front of the scanner bore and the 
signal is freely travelling through the room. 
This calibration method is limited to small animals and to in vitro studies. The
amplitude of the received calibration signal, and hence the calibration factor, 
are strongly affected by objects in the vicinity of the antenna and RF coil, 
including the sample itself. This means that the received calibration signal may 
vary with patient size and shape. In addition, an in vivo NMR system imposes 
several restrictions on calibration measurements. Inhomogeneities of the main 
magnetic field B0 and the effective radio field B1, and magnetic field drifts
compromise the measurements. Also, in a clinical setting, patients must be 
repositioned so that there is a need for flexible cabling of the calibration setup.
These problems have been addressed in the first part of this thesis.
1.3 Theoretical Background
Successful quantification depends on many sequence-, subject- or metabolite-
specific factors that influence the signal intensity and the resulting spectral peak 
area. These additional influence factors need to be taken into consideration 
when estimating tissue concentrations given in mM from signal intensities in 
the acquired spectrum. The following formula gives an overview of the 
parameters that have to be considered when quantifying metabolite (M) 
concentrations from a metabolite signal SM ((De Graaf, 2007), Equation 9.2.):
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Equation 1
 	
 	   

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 	   0 is the Larmor 
frequency, [M] is the molar concentration, V is the measured volume, and 
fsequence and fcoil denote functions that account for different signal modulations 
due to the coil and MRS pulse sequence. Sequence- specific parameters include 
the repetition time TR, the echo time TE, the number of RF pulses and their flip 
angles, and variables such as nucleus specific relaxation (T1, T2). Coil- specific 
parameters include the B1 radio-frequency field and coil load. The most 
important of these influence factors are detailed below. In addition, it is shortly 
described how different reference standards account for these influence factors.  
B0 inhomogeneity and field drifts 
Bo is the conventional symbol for the main magnetic field strength (magnetic 
flux density or induction) in a MRI system, which is given in units of magnetic 
induction, Tesla. Current clinical MR systems have a constant magnetic field 
with field strengths of 1.5 to 3 Tesla. More recently, systems with field 
strengths of up to 7 Tesla have been developed. They provide a better signal to 
noise ratio (SNR). The static magnetic field inside the scanner bore is generated 
using superconductive magnet coils and is very homogeneous in clinical state-
of-the-art scanners. However, the introduction of phantoms or a human body 
leads to inhomogeneities in the static magnetic field. Gross changes in 
resonance frequency and distortions of the static magnetic field occur at tissue 
to air and bone borders, where the susceptibility difference between the tissues 
is large. In these areas, the B0 field is inhomogeneous. In addition, materials 
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with magnetic susceptibilities very different from water, such as iron, cause 
gradient distortions and severe artifacts in the spectra.
Small changes of the main magnetic field can occur during the scans due to 
varying reasons such as the heating of passive iron shims. Continuous 
averaging of the spectra in such a drifting field will lead to broadened 
resonance lines in the final spectrum if not corrected. These in turn can lead to 
inaccuracies when spectral peak areas have to be quantified. Broad peaks start 
to overlap and signals cannot be distinguished from one another or may 
completely disappear in the noise. To avoid this, the center frequency is 
continually monitored and updated during the scan in modern MR scanners.
Coil loading and the reciprocity theorem
The load on a coil is either a phantom or a subject being imaged. The 
interaction of the patient with the RF coil causes shifts of the resonance 
frequency and damping of the coil’s resonance such that the magnetic induction
and dielectric losses in the patient cause the quality factor of the coil to 
decrease. 
The quality factor (Q) applies to any resonant circuit component; it is inversely 
related to the fraction of the energy in an oscillating system lost in one 
oscillation cycle. In a parallel tuned circuit (such as used in a MR coil), the 
quality factor is defined as: 
Q = vL/R, Equation 2
where L is the coil inductance, R is the circuit resistance, and v is the angular 
frequency. An increase in the quality factor produces a sharper frequency
response. The Q of a coil depends on the circumstances under which it is 
measured, e.g. whether it is 'unloaded' (no patient) or 'loaded' (patient). 
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Each patient induces a different load on the coil, which in turn affects the 
received signal. Any quantification method for in-vivo NMR needs to take this 
into account. 
When using a “phantom replacement method” (Buchli et al., 1994), where the 
phantom is measured before or after the subject, the coil loads for both scans 
are different. In such a case, a special calibration measurement is needed to 
correct for the differences in coil load. It is based on the reciprocity principle 
(Hoult & Richards, 1976; Hoult, 2000), which is usually formulated as follows 
in classical antenna theory (http://www.ebyte.it/library/educards/ nmr/ Nmr_ 
AntennaTheorem.html):  Given two antennas A and B placed at some distance, 
each of them can be operated either as a transmitting antenna or as a receiving 
antenna. Suppose that antenna B is kept intact, while the performance of 
antenna A as a transmitter is modified so that, for a fixed amount of input 
power, the signal received by antenna B changes by a factor F. Then the same 
modification changes also the performance of antenna A as a receiver and does 
so by the same factor F. Translated to an NMR principle, this may read  
(http://www.ebyte.it/library/educards/nmr/Nmr_AntennaTheorem.html): The 
sensitivity of a magnetic resonance assembly, used as a receiver, to nuclides
present at a point X is proportional to that assembly's efficiency, when used as
a transmitter, to generate at that same location X a radiofrequency field B1.
From this, it follows that the voltage needed to produce a 90° pulse, V90, is 
proportional to the observed signal Sobs. The calibrated signal, Scal = SobsV90 is 
therefore largely independent of coil loading (Austin et al., 1991; Michaelis et 
al., 1993).
If V90 is determined in a calibration experiment or during power optimization, 
its multiplication with the actual signal will correct for differences in coil 
loading between the calibration phantom and the actual in-vivo experiment. 
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However, B1 effects (see next section, “B1 and B1 inhomogeneities”) may only 
be corrected for using this calibration procedure if it is carried out in the same 
volume as the subsequent actual spectroscopy scan (Kreis, 1997).
B1 inhomogeneities and power optimization
B1 denotes the effective radio frequency field strength. Typical pulse 
amplitudes for Philips volume coils are 10-			
	
applied to reach this desired RF field depends on the quality factor Q of the 
coil, which in turn depends on the coil load and placement of the load within 
the coil.
The spatial distribution of the magnetic radiofrequency field varies depending 
on the coil design. Inhomogeneities of the RF field are essential sources of 
error for quantification of NMR parameters in MRI and MRS. 
For the successful quantification of metabolite concentrations, it is important to 
know the accurate transmission field distribution within a sample and reception 
sensitivity of the coil (also termed B1-, (Hoult, 2000)). The B1 transmission 
field is generally more or less homogenous when transmitting with the body 
coil or birdcage coils, however large variations occur when using surface coils 
or when measuring at high field strengths where the wavelength in the tissue is 
similar to the dimension of body structures. The induced currents further
depend on the shape of the object and its electric properties. Several approaches 
have been developed to measure the transmission and reception patterns. While 
there are different methods available to measure transmission fields (i.e. 
(Stollberger & Wach, 1996; Brunner et al., 2007)), reception field mapping 
remains a challenge (Wang et al., 2005). However, several correction methods 
using simulation methods have been implemented and the coil sensitivity can 
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be determined separately using the principle of reciprocity (see “coil loading
and the reciprocity theorem”).
For single voxel spectroscopy, localized power optimization and load 
corrections may suffice to obtain a homogenous excitation within a volume of 
interest. Alternately, adiabatic excitation schemes such as LASER (Garwood & 
DelaBarre, 2001) can be used. 
Power optimization procedures are performed previous to each scan to optimize 
the flip angle to 90°. To achieve this, the transmission power (RF drive scale) is 
adjusted according to the resistance that the patient induces into the coil and 
according to the B1 distribution until the maximal signal response is reached. 
The angle of a constant RF pulse is defined as
, Equation 3
where B1 denotes the pulse amplitude and tP is the pulse length. In order to 
maximize the bandwidth and avoid T2 decay during the pulse, the pulse 
duration needs to be as short as possible.
Several optimization schemes have been proposed (Perman et al., 1989; 
Danielsen et al., 1995). Most of the power optimization schemes executed on 
clinical scanners are either based on non-selective hard pulse experiments or 
slice-selective measurements. Although they do not correct for local B1 effects, 
they allow for correct adjustments of the flip angle for different coil loads. To 
include local B1 variations in the calibration, localized power optimization 
schemes have to be implemented. However, all power optimization schemes 
are only sufficient to achieve a correct flip angle in small volumes or single 
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voxel spectroscopy. For the normalization and quantification of CSI data, B1
corrections remain indispensable. 
Receiver Gain
The receiver gain (RG) defines the amplification of the signal coming from the 
sample. The gain of the receiver chain can be set to optimize the spectral signal 
strength so that the complete range of the receiver is filled without a truncation 
of the signal. Then, the digitization and demodulator noise become minimal. 
Setting the gain too high results in a clipped free induction decay (FID) signal. 
After Fourier transformation, this will result in a distorted spectrum. If the gain 
is set too low, only part of the voltage range of the system’s digitizer is used, 
and digitization becomes inefficient.
When performing quantification, it is important that the reference scan and the 
actual in vivo scan are acquired at the same receiver gain or that appropriate 
mathematical corrections are made after the scan.
Repetition Time
When comparing metabolite concentrations between a reference standard and a 
signal from tissue, the difference in T1 time needs to be either closely matched 
or corrected for. At a repetition time TR that is shorter than the longitudinal 
relaxation time T1, the magnetization cannot completely recover and partial 
saturation occurs. The reduction of the steady-state longitudinal magnetization 
in a simple pulse-acquire measurement is given by:
, Equation 4
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where Mz denotes the longitudinal magnetization, M0 is the equilibrium 
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every metabolite and reference metabolite when using a repetition time that is 
shorter than 5T1. When using relaxation times equal to or longer than 5T1max
(T1max being the longest relaxation time in the solution or tissue), the 
magnetization of all metabolite spins has recovered to more than 99% of M0
and one can avoid this correction. 
Echo Time
Transverse relaxation time T2 may vary considerably between a sample and a 
reference standard. The amplitude of the measured signal depends on the echo 
time TE of the sequence, according to
, Equation 5
where Mxy denotes the transverse magnetization.
For long echo time sequences, the T2 times of all metabolites need to be known 
and corrected for. Short echo times down to 10s have been achieved in 
localized spectroscopy and have been used to minimize quantification errors 
from T2 decay. However, for metabolites with short T2 relaxation times, such as 
myoinositol, even short repetition times lead to considerable signal loss.  In 
addition, short echo time spectra contain many signals form macromolecular 
compounds which lead to baseline distortions and fitting difficulties. 
Localization and Chemical Shift Displacement Artifact
The measured metabolite peak areas are directly proportional to the measured 
volumes. However, the location of the volume needs to be very accurate in 
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order to accurately quantify the metabolite concentrations in a specific region 
of interest.
In spectroscopy, identical nuclei in different molecules can be discriminated 
from one another because of their different magnetic shielding that leads to 
differences in resonance frequency. This chemical shift in turn leads to the 
selection of a different volume for each resonance when gradient localization 
schemes are used, since the frequency of spins with Larmor frequency 
in x direction is given as follows in the presence of a magnetic field gradient 
Gx:
Equation 6
The location x is therefore 
Equation 7
and the chemical shift displacement between two metabolites becomes equal to 
Equation 8
Therefore, the resonance lines of the different metabolites in a spectrum 
acquired in a “single voxel” actually stem from different volumes. The so-
called “chemical shift displacement artifact” (see  Figure 1) leads to signal 
cancellations of J-coupled metabolites, such as lactate (Edden et al., 2006; 
Lange et al., 2006; Edden & Barker, 2007) and artifacts (Kreis, 2004). In 
addition, it limits reliable spectral analysis and quantification to central regions 
of the investigated FOV when MRSI is used (Henning et al., 2008). Increases 
in pulse bandwidth diminish the displacement artifact but compete with limits 
for tissue-specific absorption rates (SAR). 
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Figure 1 Chemical shift displacement artifact. A difference in the chemical 
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Pulse Shape
Depending on the spatial selection profile of a pulse, not all frequencies may be 
equally well excited. This will lead to smaller apparent metabolite 
concentrations.
Also, when water suppression is applied, resonances close to the water 
resonance may be partly suppressed. However, such effects may be easily 
corrected for if the pulse profiles are known.
z
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Temperature
The equilibrium magnetization M0 is proportional to the Boltzmann distribution 
(Hoult & Richards, 1976), as given by:
Equation 9
Here, denotes the difference in occupation numbers of spins with magnetic 
quantum number m = ½ and m= -1/2,  is the magnetic dipole moment , 
signifies the gyromagnetic ratio, is the sample temperature, the 
Boltzmann constant and the magnetic susceptibility. Thus, when measuring 
the final MR signal, it is inversely proportional to the absolute temperature of 
the sample (Kreis, 1997). This must be taken into account when quantifying a 
metabolite signal from living tissue at 37° with a reference standard at room 
temperature. A conversion table can be found in ((Tofts, 2003) on page 306).
NMR visibility
Nuclei with very short T2 times are hardly visible in in-vivo MRS since they
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line of a Lorentzian lineshape is inversely proportional to the T2* time,
according to:
Equation 10
T2* is related to the rotational mobility of the metabolite. If the metabolite’s 
motility is strongly reduced, T2* may become very short and the measured 
metabolite concentration does not correspond to the actual concentration, as is 
i.e. the case for water, where the concentrations measured in MRS severely 
underestimate the actual concentration ((Menon & Allen, 1991; Mackay et al., 
1994; Kreis, 1997). It is generally very difficult to correct for this error. 
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Estimations of the actual concentrations can only be obtained with invasive 
methods.
Other sources of quantification errors
Magnetization transfer can occur when water suppression is applied and can 
lead to significantly lower metabolite areas. Also, movement may cause the 
spectra to appear completely normal but with decreased signal areas only 
(Kreis, 2004). A further source of quantification errors are post-processing 
steps and inaccurate fitting procedures (for further information see (De Graaf, 
2007), Chapter 9).
How do different quantification methods account for the 
confounding factors?
Table 1 displays factors that compromise quantification using the most 
common quantification schemes and the ERETIC method that has been further 
developed in this thesis. Several quantification methods are available that 
account for coil loading. One option is to measure the reference signal under 
identical loading conditions as the sample. This is done in the “internal water 
referencing method” (Thulborn & Ackerman, 1983), where the internal water 
signal is acquired in a separate measurement using the same hardware settings. 
The measurement is performed on the same volunteer and the same volume of 
interest so that the coil load remains the same. 
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Internal Reference External 
Reference
ERETIC
B1 inhomogeneities unaffected affected affected
Coil loading unaffected Partly affected unaffected
Power optimization unaffected affected affected
Receiver gain unaffected affected unaffected
TR, TE (T1, T2) affected affected affected
Temperature unaffected affected affected
Post-Processing Partly affected affected unaffected
Table 1 A summary of some parameters that influence quantification and how 
they affect the different quantification methods.
A second MRS quantification method is available that does not need 
corrections for loading, the so-called “simultaneous phantom acquisition 
method” (Murphy-Boesch et al., 1998). A phantom containing a reference 
solution with known metabolite concentrations is placed near the sample in the 
field-of-view (FOV) of the coil. Before or after the actual spectroscopy scan, a 
scan of the solution in the phantom is acquired. This calibration requires 
additional measurement time and the subject has to remain in the scanner, 
however, the quality factor of the coil remains the same for both scans. The 
ERETIC method developed for in-vivo applications (Heinzer-Schweizer et al.; 
Marro et al., 2008) also scales linearly with coil load due to inductive coupling 
of the calibration signal into the receiver coil. Since this is also the mechanism 
by which the local B1 field arising from excited nuclei in the sample couples 
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with the receiver coil, any subsequent manipulations of the data have an equal 
effect on both signals. This makes the calibration factor immune to changes in 
coil loading conditions, receiver gain settings and data processing methods.
All quantification methods are equally affected by corrections that are 
necessary for T1 and T2 relaxation times with differing TRs and TEs. Any 
method that relies on a reference signal that does not stem from the same 
volume of interest also depends on an accurate power optimization so that exact 
flip angles are reached. Also, corrections for temperature differences between 
the reference standard and the subject have to be made, and post-processing of 
all spectra needs to be performed equally.
Table 2 lists the most common quantification techniques as well as the ERETIC 
and their general advantages and disadvantages. 
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Internal Reference External 
Reference
ERETIC
Advantages - Easy to apply
- Accounts for  B1
inhomogeneities 
and errors in power 
optimization 
- Easy to 
apply when 
established
- Spectrum 
and reference 
acquired in a 
single scan
- Applicable 
for MRS
scans with all 
nuclei
Disadvantages - Requires 
assumption about 
metabolite 
concentrations
- Not all tissues 
contain a 
metabolite that can 
be used as a 
reference
- Extra scan 
time needed
- Load 
adjustments 
needed in 
some cases
- Only works 
with volume 
coils
- Requires
additional
hardware
Table 2 Advantages and disadvantages of different quantification methods.
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Chapter 2:
IN-VIVO QUANTIFICATION OF METABOLITE 
CONCENTRATIONS USING THE ELECTRIC 
REFERENCE TO ACCESS IN VIVO 
CONCENTRATIONS (ERETIC) METHOD
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2.1 Introduction
Magnetic resonance spectroscopy (MRS) is an established technique to assess 
metabolite distributions in vivo (Kreis, 1997; Kemp et al., 2007). Tissue 
concentrations of various molecules and compounds can be indicated by either 
a ratio to a reference metabolite such as total creatine (relative quantification), 
or in millimoles (also referred to as absolute quantification). While relative 
quantification is widely used, it has the major disadvantage of ambiguities 
whenever several metabolite concentrations change simultaneously, as is the 
case for most diseases. Hence absolute quantification is an indispensable tool to 
precisely determine metabolite changes for clinical diagnostics and 
physiological studies. 
The goal of this study was the development of a simple and reliable method 
that enables absolute quantification of water and metabolite concentrations 
based on in vivo 1H MRS. More specifically, the method should be applicable 
to clinical diagnostics, where it ought to yield reproducible results with no 
additional measurement time needed, and no interference with already 
implemented measurement procedures (including proton decoupling for multi-
nucleus acquisitions). Also, it ought to be robust in disorders that lead to 
structural changes and thus changes in tissue water concentrations.
Absolute quantification based on internal water referencing has been available 
for a long time (Thulborn & Ackerman, 1983; Barker et al., 1993) and is the 
current method of choice. It accounts for B1 variations across the field of view, 
but imposes problems when assessing diseases that lead to alteration of tissue 
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water concentration (Helms, 2001; Laule et al., 2004) and relaxation behavior. 
Simultaneous phantom acquisition methods (Narayana et al., 1989; Hennig et 
al., 1992; Ernst et al., 1993; Kreis et al., 1993) and phantom replacement 
methods (Buchli & Boesiger, 1993; Duc et al., 1998) have also been 
successfully used for many scientific studies, but these methods have never 
been established for routine clinical diagnostics. 
The ERETIC (Electric REference To access In vivo Concentrations, (Barantin, 
1997; Akoka et al., 1999; Akoka & Trierweiler, 2002) method was introduced 
as an innovative approach to in vivo quantification by Barantin et al. (Barantin, 
1997). It uses a synthetic reference signal that is induced by means of a small 
loop coil that couples to the RF coil. This low-power reference signal is turned 
on during the acquisition only and simulates the free induction decay (FID) of 
spin signals, which will give rise to an additional peak with Lorentzian line 
shape in the spectrum. 
ERETIC offers several advantages in that (1) it is applicable to all nuclei, (2) 
spectra can be acquired simultaneously with the artificial reference signal in a 
single scan, (3) scaling of the received signal with the coil load and receiver 
gain is achieved and (4) the signal intensity is not affected by different medical 
conditions. Re-calibration is not necessary for every measurement, leading to 
an easy handling of the calibration method for clinical applications. In addition, 
ERETIC signal amplitude is independent of TE and TR. The reference signal 
does not correct for B1 variations across a volume – for this reason, its 
successful application depends on the use of a homogeneous volume coil and/or 
B1 mapping and correction. In addition, the ERETIC method is susceptible to 
errors in power optimization; however changes in coil loading, matching, 
receiver gain, and data processing (Marro et al., 2008) are directly included. 
Further effects on estimated metabolite concentrations, such as magnetization 
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transfer, frequency response of the RF pulse, and MR visibility of a molecule, 
are described in more detail by Marro et al (Marro et al., 2008). 
While quantification with ERETIC has been proven to be an accurate method 
for the assessment of concentrations of various dissolved compounds using 
ultra-high field NMR spectrometers (Barantin, 1997; Akoka et al., 1999; Akoka 
& Trierweiler, 2002; Michel & Akoka, 2004), only preliminary results from in-
vivo spectroscopy measurements have been shown using clinical MR scanners 
(Barantin, 1997; Marro et al., 2008). In the earliest in-vivo ERETIC (Barantin, 
1997) implementation, the ERETIC loop was attached at the front of the 
scanner bore in a fixed position and the calibration signal was transmitted via 
radiation, which leads to signal variations whenever the mutual coupling 
between the loop and the receive coil changes. Marro et al. (Marro et al., 2008)
have modified the ERETIC approach to an inductive injection of the signal into
the receive coil, thus directly considering changes in coil loading and receiver 
gain settings.  Using this approach, cables must be run through the scanner 
bore. Transmission of the calibration signal via an electrical transmission line 
may cause parasitic coupling and thus inaccurate quantification results when 
cables are not carefully repositioned for each measurement. Another source of 
error are B1 inhomogeneities.
In order to solve these problems, a new implementation scheme based on fiber 
optic transmission of the ERETIC signal and induction into a transmit/receive 
birdcage head coil on a clinical 3T scanner is presented in this work. A low-
power transmit channel is used for transmission of the artificial reference peak. 
Stability, scaling with coil load and a small inter-scan variability of the 
ERETIC signal are demonstrated. With this optical setup, reliable and 
reproducible quantification results were obtained for 1H MRS on a clinical 3T 
system in vivo. The comparison of brain 1H MRS quantification results based 
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on the ERETIC approach is in accordance with internal water reference 
calibration in healthy volunteers and meta-analysis literature values (Keevil, 
1998). 
2.2 Theory
The concentration cmet of any given metabolite in an in-vivo spectrum can be 
determined by comparing its intensity to the ERETIC peak, according to the 
following formula (Akoka et al., 1999):
,
,
* *ERETIC met invivo
met
ERETIC invivo
k c A
c
A

Equation 11
Here, k accounts for the number of protons contributing to a resonance line, 
cERETIC is the equivalent concentration of the calibrated ERETIC peak and Amet
and AERETIC,invivo stand for the areas of the metabolite and ERETIC peaks, 
respectively. The equivalent concentration of the ERETIC peak must be 
determined beforehand with the known concentration of a calibration solution. 
There, the peak area of the ERETIC peak AERETIC,invitro is compared to the peak 
area of the calibration peak Acalib and multiplied by the concentration of the 
calibration solution ccalib [Equation 12]. 
Equation 12
For an accurate calibration of a metabolite signal with a phantom, T1 saturation 
and T2 times of phantom metabolites compared to in-vivo relaxation times need 
,*calib ERETIC invitro
ERETIC
calib
c A
c
A

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to be taken into account (Mlynarik et al., 2001). Additionally, a temperature 
correction must be applied to correct for the offset in spin populations between 
the phantom and the brain (Venkatesan et al., 2000), and volume corrections 
must be made depending on the voxel size of the acquired spectra compared to 
that used for the reference spectrum (Kreis et al., 2001).
2.3 Methods
Signal generation
When quantifying the spectra with any software package such as LCModel
(Provencher, 1993), jMRUI (Naressi et al., 2001), or TDFDfit (Slotboom et al., 
1998), an FID- like signal with line broadening adjusted similarly to that of the 
real resonance lines is needed. Frequency drifts during the scan due to 
temperature changes or other variables must be compensated for by means of a 
communication path between the signal generator and the scanner. In this work 
these issues are readily addressed by using the spectrometer itself to generate 
the ERETIC signal. An amplitude modulated RF pulse is sent through a 
separate channel of the system. The frequency is thus updated whenever the 
system frequency changes, so that additional line broadening due to averaging 
is avoided.
Signal transmission
When using a setup based on electrical signal transmission, the ERETIC signal 
suffers from considerable instabilities when cable positions are changed. This is 
due to the fact that any electronic device, such as the T/R switch or cabling, 
may act as a parasitic radiation source of its own. Therefore, several coupling 
Chapter 2: ERETIC 39
paths are present simultaneously between the signal source and RF coil, which 
can lead to signal cancellations. Depending on the strength of confounding 
signals, the ERETIC reference signal that is coupled to the receive coil can vary 
by more than 70 percent from the mean value. An example of a scan with three 
extreme cable positions is shown in Figure 2. To achieve reliable quantification 
results, cable traps and careful grounding of the wires are required to lessen 
parasitic coupling, and the ERETIC cable must be positioned in the same way 
for all scans. To avoid such rigid constraints on cable positioning, we here 
propose a new implementation of the ERETIC method for in-vivo applications, 
featuring an optical fiber RF transmission system to provide a flexible scanning 
setup for clinical applications. 
For multi-nuclear signal acquisition, only two transmit channels are available 
on most commercial systems, i.e., one for proton and one for other nuclei. In 
order to enable parallel use of all channels for future multi-nucleus 
applications, we here make use of an auxiliary low-power RF channel to 
generate the ERETIC signal, leaving the proton and multi-nuclear channels free 
to function normally. Enhancements of signal-to-noise ratio and spectral 
resolution using multinuclear techniques are thus unaffected.
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Figure 2 Example of measuring the ERETIC amplitude at extreme cable/fiber 
positions. A double shielded coaxial cable was used for the electric 
transmission. The figure displays ERETIC peaks acquired with the cable (left) 
and optical fiber (right) positioned in different ways (see schematic, bottom):
1. cable/fiber running along the scanner bore, 
2. cable/fiber running away from the scanner bore, and 
3. cable/fiber running through the scanner bore.
The ERETIC amplitude stays stable with the optical setup while showing large 
variations due to prasitic coupling when it is injected through the cable.
Signal injection
The ERETIC loop must be placed as close as possible to the receiver coil in 
order to couple the signal inductively and to avoid electric coupling effects. 
Loop dimensions must be minimal so that the transmitted ERETIC signal 
remains stable with varying coil loading. In the setup presented here, coupling 
through electric fields is further reduced by using an end-capped birdcage coil24
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whose ground plane (RF mirror) separates the load from the ERETIC loop and 
provides stable grounding. 
Hardware implementation
The proposed technique was implemented on a Philips Achieva 3.0 T scanner 
(Philips Healthcare, Best, The Netherlands) with a modified commercial 
transmit/receive birdcage proton coil. During acquisition, the ERETIC signal 
was sent to a loop that was placed behind the rear RF mirror of the 
transmit/receive head coil. 
The broadband tune channel of the system is used to generate the ERETIC 
signal [Figure 3, top] at any given resonance frequency, such as that of 1H, 13C, 
19F or 31P.
A directly modulated RF-over-fiber link was used to transmit the ERETIC 
signal from the spectrometer to the coupling loop. The link consists of a 
matching network, a directly-modulated light emitting diode (LED), a polymer 
optical fiber and a photodiode detector which is connected to the ERETIC loop 
[Figure 4, left]. This setup guarantees that only the signal that is coupled 
through the ERETIC loop will be picked up by the receive coil and that all 
sources of parasitic coupling are eliminated. 
A high-frequency LED (L9534, Hamamatsu, Japan) is used as the modulator, 
while the injector loop contains a non-magnetic PIN photodiode powered by a 
DC voltage source available at the birdcage head coil and is positioned behind 
its rear RF mirror. The injector loop couples inductively with one of the 
birdcage legs near the point where it is connected to the RF mirror [Figure 3, 
bottom]. 
42 Chapter 2: ERETIC
Figure 3 Top: Signal paths from the coils to the spectrometer. An auxiliary 
channel is used for transmission of the ERETIC signal. Bottom: The ERETIC 
loop as it is placed behind the rear RF mirror of the birdcage
coil (left). The setup is patient-friendly and easy to handle (right).
13
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Software
The ERETIC pulse shape, phase, decay time constant, amplitude, frequency 
and phase cycling schemes can be adjusted directly at the scanner console. 
Frequency updates during a scan with multiple averages result in a 
simultaneous update of the ERETIC signal. 
2.4 Validation and test measurements of the ERETIC 
setup
1) Scaling with variable coil load
According to theory, the ERETIC and metabolite signals scale similarly with 
changes in coil load. To show concordant scaling behavior the NAA and 
ERETIC signals with varying coil load, different loading conditions were 
simulated using resistors. Using this setup, inaccuracies such as B1 effects, 
changes in scanner settings and automatic power optimization, that may arise 
when the load is adjusted through the use of different phantoms, can be 
excluded. Six 1k resistors in parallel were connected to the coil ports at the 
back of the T/R coil as shown in Figure 4, right. Switches allowed any 
combination of resistors to be included or excluded. To ensure equal loading of 
the birdcage coil’s two orthogonal modes, two such boards were used and 
connected to the corresponding ports. These boards included a T/R switch, 
which ensured that the resistors were loading the ports during acquisition only, 
while in transmit the resistors were disconnected to ensure that transmit B1 and 
power settings of the scanner remained unchanged. 
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Measurements were carried out using a spherical MRS phantom (MRS 
“Braino” phantom, GE Healthcare). Scans were acquired using a single voxel 
PRESS sequence (TR=2000ms, TE=144ms, voxel size: 2x2x2cm) with 64 
signal averages per loading condition. Receiver optimization and other scan 
preparation settings were kept constant throughout the entire experiment. Load 
scaling as a function of parallel resistance was compared for the NAA and the 
ERETIC signal.
Figure 4 Left: Schematic of the optical setup. The signal is amplified before it 
is sent to the scanner room and finally reaches the injector loop. Right:
Simplified schematic of the resonance circuit with 6 parallel resistors (Rparallel)
added to the birdcage coil. The resistors have a value of 1 kV each. A set of 
resistors was added to each quadrature port of the coil in order to load both 
orthogonal modes in a similar fashion.
2) Concentration series
To demonstrate calibration capabilities of the ERETIC method, phantoms 
containing variable glycine (Gly) concentrations [10-50mM] were prepared and 
quantified. Phantoms were prepared using a precision balance (precision: 
0.0001g) to reach an error estimate below 1%. Settings for each scan were as 
follows: TR=2000ms, TE=29ms, voxel size=1x1x1cm, 128 averages. A 
preparation phase including automatic power and receiver gain optimization 
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was performed prior to each measurement. The phantom with the highest 
concentration and SNR was used for calibration.
3) Sensitivity to movements (Inter-scan variability)
The ERETIC signal must remain stable when changing patient positions and 
after moving the coil out and back into of the scanner bore. To test signal 
stability, PRESS scans (TR= 2000, TE= 144ms, voxel size = 2x2x2cm) were 
made using the “Braino” phantom. After 60 signal averages the coil was moved 
out of the scanner bore, cables were repositioned and the coil was placed back 
to the iso-centre of the bore. The scanning was then continued without 
adjustments of the scan settings. This procedure was repeated 10 times. 
4) Short-term and long-term stability of the ERETIC signal
Short-term stability of the calibration signal was assessed in a time series scan 
with 1024 individual acquisitions using the “Braino” phantom. A PRESS 
sequence (TR=5000 ms, 2 signal averages/dynamic, TE = 29 ms) accounting to 
a total measurement duration of 2 hours was scanned. The ERETIC signal was 
plugged in at the beginning of the measurement. Long-term stability was 
assessed using a long-time PRESS protocol (TR=10’000 ms, TE=29 ms, 10 
signal averages/dynamic) of 11 hours and 48 minutes. The ERETIC signal had 
been plugged in beforehand to avoid warm-up effects (see Results). A longer 
repetition time was chosen to limit the amount of data acquired while having no 
influence on signal amplitude. The spectra were analyzed for the stability of the 
ERETIC signal by measuring its amplitude in the magnitude spectrum.
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5) In-vitro Reproducibility
The intrinsic reproducibility of a quantification method cannot be conclusively 
determined in-vivo due to confounding factors such as inter-and intra-subject 
variability of metabolite concentrations. The random error of the ERETIC 
quantification was therefore compared to that of the internal water reference by 
repeating a single-voxel PRESS scan including all preparation steps, such as 
automatic power and receiver gain optimization 20 times in a phantom 
containing natural metabolite concentrations. Parameters were as follows: TR= 
2000ms, TE=29ms, 64 signal averages, voxel size = 2x2x2cm.
6) In-vivo acquisition of single voxel spectra and concentration determination
To determine the robustness and reproducibility of the ERETIC reference 
standard for in vivo metabolite quantification, the ERETIC quantification 
method was cross-validated with the internal water reference method in healthy 
volunteers and quantification results were compared with literature values. In 
addition, the proposed optical signal transmission was compared to ERETIC 
signal transmission through an electrical cable with quasi fixed cable position. 
Experiment 1. To assess the reproducibility of quantifying tissue concentrations 
of metabolites  in vivo with ERETIC, the ERETIC-signal to metabolite ratio 
was measured in three independent scans each for six subjects (age = 28  8.8 
years). The subjects were repositioned between the scans and all preparation 
steps were repeated. Voxels were placed in the centrum semiovale (CSO) of the 
brain and single voxel PRESS scans (TR=2500ms, TE= 47ms) were performed. 
Each scan was performed twice, once using an electrical transmission of the 
ERETIC signal and the second time using the proposed optical ERETIC signal 
transmission. For the electrical transmission, the ERETIC cable was carefully 
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repositioned for each measurement inside the scanner bore to avoid parasitic 
coupling. The position of the coaxial cable was entirely fixed between the 
signal generator and the entrance of the scanner bore and the cable position 
inside the scanner was reestablished with an accuracy in the mm range.
Experiment 2. In-vivo brain metabolite concentrations were assessed in five 
healthy subjects (age = 283.9 years) for cross-validation of the ERETIC 
reference method using the proposed optical signal transmission setup with the 
internal water reference method. In an independent measurement series, water 
concentrations were determined in six subjects (age = 285.8 years). All single 
voxel PRESS (TR=2500ms, TE= 47ms) spectra were acquired in the CSO. 
The above experiments were then followed by metabolite signal fitting and 
internal water referencing using LCModel. While ERETIC peak fitting is 
possible using LCModel fitting the ERETIC peak using TDFDfit was found to 
be more reliable (see Discussion) and was therefore used to obtain the 
amplitude of the reference peak. 
The obtained concentration values were subsequently corrected for 
temperature, voxel volume, and T1 and T2 using literature values (Mlynarik et 
al., 2001). A water reference scan was acquired for all metabolite spectra to 
allow quantification of the metabolite concentrations with the internal water 
reference method.
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2.5 Results
1) Scaling with variable load
The scaling of ERETIC signal amplitude under variable loading conditions 
[Figure 5] is in good agreement with that of NAA and demonstrates the 
robustness of accurate quantification with the ERETIC method under variable 
loading conditions. The coefficient of variation of the NAA to ERETIC signal 
ratio is 2.8%. 
Figure 5 Scaling of the NAA (grey diamond) and ERETIC (square) signals with 
varying load. 64 spectra were acquired for each data point. The error bars 
denote the intra-scan standard deviation of the integrated peak areas and of the 
ratios. The NAA signal was scaled (white diamond) to visualize the similar 
scaling behavior of both signals with variable load. The ERETIC/NAA ratio 
(scaled up 3 times for better visibility) is shown as triangles.
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2) Concentration series
In-vitro quantification with a series of five phantoms with increasing Gly 
concentration show accurate results (R2=0.99) even when all preparation steps, 
such as automatic power and receiver gain optimization, are performed 
individually for each scan [Figure 6]. 
Figure 6 Calibration curve for Gly concentrations varying from 10 to 50 mM. 
The R2 of the measured versus prepared Gly concentrations is 0.99, showing 
the accuracy of quantification with the ERETIC method.
3) Sensitivity to movements (Inter-scan variability)
When the phantom is moved out of the scanner and back in between 
measurements and the receiver gain is not changed, the ERETIC signal exhibits 
a coefficient of variation of 2.83%.
4) Short-term and long-term stability of the ERETIC signal
After an initial warm-up phase, the ERETIC signal remains stable over a 
measurement time of several hours. The initial drift is attributed to a 
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temperature transient when the circuit is switched on. This effect can be
avoided by switching the circuit on half an hour before starting the scan.
When omitting the warm-up time from the analysis, the coefficient of variation 
is 0.67%, while the minimal and maximal value differ by 1.41% and 0.95% 
from the mean [Figure 7, top].
In the 12 hours scan, the coefficient of variation was 2.16%, with minimum and 
maximum values differing by 3.79% and 3.40% from the mean value [Figure 7, 
bottom]. 
5) In-vitro Reproducibility
When repeating a single-voxel scan 20 times in a calibration phantom and 
quantifying all metabolite concentrations with LCModel, the accuracy of the 
internal water scaling method exhibits a mean error of 1.58% for the 
quantification of NAA, Cho, and Cre, while the ERETIC method performs 
slightly worse with a mean error of 2.83%. 
6) In-vivo acquisition of single voxel spectra and concentration determination
Experiment 1.
The coefficients of variation between scans for the optical setup were 9.1% for 
the ratio NAA/ERETIC (range across subjects: 2.5%-14.8%), 7.3% (3.2-
12.8%) for Cho/ERETIC, and 6.2% (3.3-9.2%) for Cho/ERETIC. Similar 
values were obtained when transmitting the ERETIC signal through an 
electrical cable in the case of carefully repositioned cable postions; coefficients 
of variations were 7.9% (3.9-16.1%) for NAA/ERETIC, 9.3% (4.8-15.0%) for 
Cho/ERETIC, and 9.5% (6.4-13.4%) for Cre/ERETIC. 
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Figure 7 Top: Results of the short-term measurement of the ERETIC amplitude 
on an expanded scale: A warm-up phase of approximately 30 minutes is 
required. Thereafter, the ERETIC signal remains stable within a low coefficient 
of variation of 0.66% when acquiring spectra with a signal averaging factor of 
130 (squares). The diamonds denote the ERETIC amplitude of the actually 
acquired spectra. Bottom: Long-term measurement after the warm-up phase: 
The coefficient of variation for this series is 2.16% when considering 130 
signal averages (squares).
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Experiment 2.
In-vivo ERETIC quantification results [Figure 8, Table 3] from the centrum 
semiovale of five subjects are in agreement with values obtained in the 
literature (Michaelis et al., 1993; Pouwels & Frahm, 1998; Kaiser et al., 2005; 
Baker et al., 2008), as well as those obtained using the internal water reference 
standard. The product-moment correlations of the concentration values 
determined with internal water referencing and ERETIC are 0.98 for NAA, 
0.93 for Cho and 0.91 for Cre and indicate that the two methods correspond 
well to each other in healthy tissue. The determined NMR-visible water 
concentrat)*+

,,,,,-.*)%.*/"
 	%	
content of brain tissue (Ernst et al., 1993)). The measured values of 35582 
2239mM are in good agreement with previously published literature values of 
35888  011*).*2,3 (Ernst et al., 1993)) and 37277  1722mM 
).*2431 (Warntjes et al., 2007)).
2.6 Discussion
The goal of this study was to develop a quantification method which is suited 
for clinical applications. Major challenges were the achievement of a stable 
ERETIC signal, maintaining the availability of all transmit channels for future 
multi-nucleus measurements, and the construction of a hardware and software 
setup which can be readily used for clinical measurements. 
Similar reproducibility was achieved for the in-vivo scans with the optical and 
electrical setup when the coaxial cable utilized for the latter setup is carefully 
repositioned (methods, section 6). However, maintaining stable cable positions 
is not practical under clinical conditions, where patients and coils are moved in 
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and out of the scanner bore. With the optical setup presented above, 
quantification can be performed irrespective of fiber positioning and enables
flexible scanning. The received coefficients of variation of both the electrical 
and optical transmission are in agreement with literature values (Marshall et al., 
1996) that were measured using the same localization technique. The measured 
variability between the scans is due to a combination of errors in repositioning 
the VOI, subject motion, and the limited signal to noise ratio (Marshall et al., 
1996).
Figure 8 Results of the in-vivo quantification with the absolute concentration 
values obtained with ERETIC calibration and the internal water reference 
method. A PRESS sequence was used to acquire spectra from five subjects.
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NAA
concentration/mM
Cho 
concentration/mM
Cre concentration/mM
ERETIC Internal 
Water
ERETIC Internal 
Water
ERETIC Internal 
Water
S1 9.9 10.4 1.9 1.9 6.2 5.9
S2 11.5 11.9 1.8 1.8 6.5 6.2
S3 11.2 11.3 1.8 1.7 6.9 6.3
S4 9.1 10.1 1.5 1.6 5.7 5.7
S5 9.1 9.8 1.9 2.0 6.8 6.7
Average ( 1 SD) 10.11.0 10.70.8 1.80.1 1.80.1 6.40.4 6.20.3
Literature values1 12.10.8 1.70.3 6.70.4
Literature values2 9.50.4 1.80.1 6.60.3
Literature values3 11.21.2 1.80.3 6.10.8
Literature values4 10.60.8 1.70.3 5.70.6
Table 3 Metabolite concentration values measured using internal water 
reference for subjects one through five (S1–S5) and averages over all 
subjects. Literature values: (1) Baker et al.,2008: 3T single-voxel PRESS 
study, corrections for T1, T2 and cerebrospinal fluid content, internal water 
referencing; (2) Kaiser et al.,2005.: 4T single voxel STEAM study, no 
corrections applied, internal water referencing; (3) Michaelis et al, 1993.: 2T 
SV STEAM study, constant T2 correction for all measured locations, phantom 
calibration; (4) Pouwels et al, 1998.: 2T SV STEAM study, coil load 
correction, LCModel quantification
In addition to a high in-vitro reproducibility (see methods, section 5), quantified 
water and metabolite concentrations recorded in-vivo are in the ranges 
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commonly reported in literature. The values in healthy volunteers compare well 
to the concentrations determined with the internal water reference method. 
The ERETIC pulse has been completely integrated into the scanner software, 
which enables the user to turn on the quantification at the scanner console and
to modify the ERETIC phase, shape, and amplitude for the spectroscopy 
measurement.
With this setup, the obtained quantification results exhibit similar measurement 
uncertainty as phantom replacement methods, yet allowing for calibration in a 
single scan and without manual adjustments of receiver gain settings and load. 
Accurate quantification still requires compensation for B1 field 
inhomogeneities.
The use of a birdcage coil significantly reduces B1 field variations compared to 
other coil designs such as surface coils. In addition, the transmit B1
inhomogeneity can be mitigated with adiabatic excitation schemes such as 
LASER (Garwood & DelaBarre, 2001) or precise power optimization based on 
iterative approaches as used in this work. Also, the transmit B1 may be 
measured to correct for variations in a post-processing step. On the other hand, 
the receive B1 field can change by more than 10 per cent over the entire brain 
when measuring proton spectra with such a transmit/receive volume coil (Wang
et al., 2005).  For the experimental conditions considered in this work and at 
higher field strengths, transmission and reception patterns differ significantly 
and one may not be deduced from the other (Hoult, 2000). Coil receive 
sensitivity calibration would further improve the quantification results (Kreis, 
1997). Its inclusion in the quantification with ERETIC based on the approach 
by Wang et al. (Wang et al., 2005) or simulations (Moyher et al., 1995) is a 
topic of ongoing research.
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The minor differences between metabolite concentrations determined with the 
internal water calibration and the ERETIC reference methods (see methods, 
section 5) may be due to errors in the estimation of parameters. These include 
the assumed water content for white matter in case of internal water 
referencing, the estimation of the temperature correction factor when 
quantifying with the ERETIC method, or flaws in the determined T1 and T2
times. The slightly worse accuracy of the ERETIC method in comparison to 
internal water referencing may be the result of errors in automatic power 
optimization, which result in excitation angles slightly different from the 
nominal pulse angle and therefore altered metabolite signal amplitudes. 
However, this effect is not specific to the ERETIC method, but applies also to 
all phantom calibration methods.
Metabolite fitting and automatic internal water referencing were performed 
using LCModel, while the ERETIC peak was fitted using TDFDfit. This tool is 
better suited to fit the ERETIC peak since it allows for adjustment of individual 
lineshapes. The simple exponential decay used for the ERETIC pulse leads to a 
Lorentzian curve in the spectrum, while LCModel expects the Voigt shape 
exhibited by all metabolites. Future implementations will include an additional 
Gaussian windowing of the ERETIC pulse shape in order to enable a more 
streamlined spectral quantification with widely available fitting and 
quantification software such as LCModel or jMRUI. 
2.7 Conclusion
In this paper, we have demonstrated the applicability of ERETIC in a clinical 
environment. The proposed setup, which employs an optical transmission line, 
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enables accurate quantification of metabolite concentrations in a single scan. In 
vivo quantification yields reliable results that are in good agreement with 
literature values and with internal water referencing.
For proton spectroscopy, quantification using the ERETIC method leads to 
accurate metabolite concentrations even in cases where the tissue water 
concentration or water relaxation behavior (T1, T2) are altered. Such changes 
may occur in various lesions, whose investigation is currently one of the main 
applications for clinical 1H MRS. ERETIC is therefore ideally suited for the 
acquisition of reliable quantitative 1H spectra in a clinical environment.
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Chapter 3:
QUANTIFICATION OF METABOLIC 
PARAMETERS BY 31P MRS
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3.1 Introduction
Phosphorus spectroscopy. 31P spectroscopy has become a popular means to 
assess dynamic metabolic processes in muscles in vivo. Its relatively high 
sensitivity (approximately 7% of 1H), together with a 100% natural abundance 
and the lack of a baseline allows for the acquisition of high quality spectra 
within a few minutes. Furthermore, the chemical shift dispersion is large (20-
30ppm), so that an excellent spectral resolution can be reached. In addition to 
the determination of all fundamental metabolites that are involved in energy 
metabolism, functional metabolic parameters such as pH (Petroff et al., 1988), 
Mg2+ concentrations (Gupta & Moore, 1980), equilibrium constants of a certain 
fraction of creatine kinases (Wallimann, 1996), and ADP concentrations 
(Veech et al., 1979) can be indirectly deduced. 
Internal reference standard. Accurate quantification of millimolar metabolite 
concentrations presents a lot of challenges (see Chapter 1:
QUANTIFICATION). In contrary, relative quantification is comparatively 
straightforward if a few rules are followed. The metabolite that is chosen as a 
standard inside the measurement voxel will experience the same local B1 and 
B0 fields, and receiver gains, coil loads and temperatures that are equal to the 
quantified metabolite. 
Internal water referencing has previously been used for quantification of 
metabolites in 31P spectra. To achieve this, dual-tuned coils are needed 
(Thulborn & Ackerman, 1983; Buchli & Boesiger, 1993). However, an exact 
calibration for the sensitivity difference between the water and 31P channel is 
required for an accurate quantification, which requires a lot of diligence since 
that calibration factor also depends on the coil load (for further reference, see 
(De Graaf, 2007) and (Buchli & Boesiger, 1993)). .
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Adenosine tri-phosphate (ATP) has been used as an internal reference in many 
muscle physiology studies (i.e. in (Taylor et al., 1986; Blei et al., 1993; Conley
et al., 2000), among many others). It is the universal form of immediately 
available energy in the cell. The ATP concentration in skeletal muscle is kept at 
approximately 8.2mM and only varies little if the system is only mildly 
challenged (De Graaf, 2007). In previous studies, no differences in ATP 
concentration could be found between trained and untrained subjects (Nevill et 
al., 1989) and relative resting PCr/ATP ratios did not differ between trained 
and untrained groups (McCully et al., 1989; Johansen & Quistorff, 2003).
Calibration with an internal reference of the same nucleus, such as ATP in the 
case of 31P spectroscopy, is especially convenient if surface coils are used for 
the acquisition of un-localized spectra. Although their field homogeneity is 
low, surface coils have a high sensitivity in proximity to the surface. The 
localization area corresponds approximately to a hemisphere of one coil radius 
in which the sensitivity decreases with increasing distance from the coil. 
Surface coils may be used in combination with localization schemes such as 
ISIS. However, unlocalized spectroscopy scans are often performed for a better 
SNR. If they are performed using adiabatic pulses at a TR > 5*T1, the B1 and 
T1 sensitivity can be eliminated altogether (De Graaf, 2007).
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3.2 31P metabolites in muscle
Adenosine tri-phosphate (ATP)
Figure 9 Adenosine tri-phosphate (ATP) molecule with ribose ring, adenine 
moiety and tri-phosphate group. The terminal phosphate is split off in the 
process of energy release. Image source:
http://en.wikipedia.org/wiki/Adenosine_triphosphate.
ATP consists of a sugar ring, an adenine moiety and a terminal tri-phosphate 
group (Figure 9). Its phosphate groups can be split off by enzymes to release 
energy for muscle contractions (Figure 10, Figure 11), for the synthesis of 
biological membranes or organic molecules. In the splitting process, adenosine 
di-phosphate (ADP) and adenosine mono-phosphate (AMP) are formed and 
inorganic phosphate is released. Approximately 32.2kJ/mol energy are obtained 
for each splitting process. If ATP exceeds the equilibrium concentration in a 
healthy subject, the phosphocreatine stores are replenished, and if it is below 
equilibrium concentration, energy generating processes are activated. These 
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involve oxidative phosphorylation, glycolysis and transfer of a phosphate group 
from phosphocreatine to ADP.
In 31P spectroscopy, ATP gives rise to three distinct peaks (see Figure 12) at -
4,## )-ATP), -522## ).-ATP), and -60## )7-ATP). The muscle 
ATP concentration remains constant throughout exercise and at rest (see 
Introduction). In the muscle, ATP is hydrolyzed during muscle contraction. 
Myosin, a motor protein, moves along actin fibers in the contractile parts of the 
myofibrils, the so-called sarcomeres (Figure 10). This then leads to a shortening 
of the muscle.
Figure 10 Cross-section through a sarcomere. Movements of myosin (thick 
filaments) along the actin fibers (thin filaments) lead to a shortening of the 
muscle. Image source: http://de.wikipedia.org/wiki/Sarkomer.
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Figure 11 Myosin, a motor protein, moves along actin fibers in the muscle and 
enables muscle motion through the use of ATP. Drawing according to the 
findings of (Rayment et al., 1993).
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Adenosine di-phosphate (ADP)
Adenosine di-phosphate (ADP) is the breakdown-product of ATP and plays an 
important role in the body as a signaling molecule. It is involved in regulating 
processes such as glycolysis, gluconeogenesis, and ion transport (Koretsky et 
al., 1990). In MR spectra, the resonances of ADP appear at -4,##)-ADP), 
and -18##).-ADP). However, they remain invisible due to the low NMR-
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(Roth & 
Weiner, 1991). Cellular reactions near equilibrium can be used for the 
calculation of free metabolites at low concentrations. The free ADP 
concentration can be calculated from
Equation 13
The pH can be determined using the chemical shift difference between Pi and 
PCr. However, one has to be aware that this requires assumptions on the 
equilibrium constant Keq of the creatine-kinase reaction and creatine (Cr) 
concentration values (i.e. 15% of the total creatine pool). The equation does not 
account for variable Mg2+ binding and the effect of pH on the equilibrium 
concentration, which imposes problems for the calculation of ADP 
concentrations under exercise (Roth & Weiner, 1991).
Phosphocreatine (PCr)
Phosphocreatine (PCr), also known as creatine phosphate, acts as high-energy 
reserve. The energy given off from donating the phosphate group is used to 
regenerate ATP. Phosphocreatine plays a particularly important role in tissues 
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that have high, fluctuating energy demands such as brain and muscle. Its stores 
can be rapidly depleted in the first few seconds of muscle contraction before the 
onset of glycolysis and oxidative phosphorylation. In addition, phosphocreatine 
is an energy shuttle that can diffuse from the energy-producing sites such as 
mitochondria, to the energy-utilizing sites. In MRS, the resonance of PCr is 
assigned a chemical shift of 0ppm (Figure 12).
Inorganic Phosphate (Pi)
Inorganic phosphate is a prerequisite for oxidative phosphorylation in muscle 
mitochondria (for further reference see Chapter 5: Introduction) and reaction 
product of ATP hydrolysis (Equation 14):
Equation 14
In addition, it is a buffering agent that is involved in the regulation of metabolic 
pathways in muscle cells (Walsh et al., 2002), such as glycolysis (Khoja, 1986; 
Rush & Spriet, 2001).
In skeletal muscle, the Pi concentrations are generally low (around 3-5mM) and 
the resonance is sometimes completely missing in muscle spectra at rest. If 
present, the Pi resonance is found at 5.02ppm (Figure 12).
Phospho-Monoesters (PME) and Phospho-Diesters (PDE)
The phosphomonoester and phosphodiester peaks are not always well visible in 
muscle spectra whereas they are easily recognized in brain spectra. The main 
constituents of the PME resonance are phosphorylethalonamine (PE) and 
phosphorylcholine (PC), whereas PDEs are mainly composed of glycero-
phosphorylcholine (GPC) and glycerol-phosphorylethanolamine (GPE). PMEs 
and PDEs are involved in membrane synthesis and degradation. Their 
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resonances can be found at 5.88 ppm (PC), 6.78 ppm (PE), 2.76ppm (GPC), 
and 3.20 ppm (GPE). 
Figure 12 Typical 31P MRS spectrum of a human muscle. Image source: (De 
Graaf, 2007), Figure 2.29.
3.3 Parameters that can be accessed using 31P MRS
Measurement of the pH 
The chemical shift of certain metabolites that are visible by using 31P MRS is 
strongly influenced  by the pH and the concentration of Mg2+.  A protonated or 
complexated form of a metabolite will have a different resonance than its non-
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protonated/complexated equivalent. However, if the exchange between these 
two forms is fast, only one peak with an average resonance frequency can be 
seen in the spectrum. The frequency of that peak then indicates the ratio of the 
two forms of the metabolite. Inorganic phosphate is a good indicator for pH 
changes (pK = 6.77), while the PCr resonance frequency stays approximately 
constant in the physiological pH range (pK = 4.3).   
Figure 13 pH calibration curve for the Pi-PCr system as used for the 
determination of intracellular pH with in vivo 31P MRS. The curve is described 
by Equation 15 	 !""#HA $%&%
#A=5.70 ppm. Image source: 
(De Graaf, 2007), Figure 2.30.
The expected chemical shift differences between Pi and PCr at different pH 
values are shown in Figure 13. The pH can be calculated using a modified 
Henderson-Hasselbalch equation (Petroff et al., 1988):
Equation 15
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<	/	=
	observed chemical shift of Pi=A =HA are the 
chemical shifts of the protonated and unprotonated forms of Pi (at 5.7 and 
3.23ppm, respectively), and pKA is the logarithm of the equilibrium constant 
for the acid-base equilibrium between the protonated and unprotonated form of 
Pi.    
PCr recovery constant and oxidative muscle function
Phosphocreatine is depleted during exercise and recovers subsequently. It has 
been shown that the rate of phosphocreatine (PCr) resynthesis after muscle 
exercise depends entirely on mitochondrial respiration (Taylor et al., 1983; 
Arnold et al., 1984). It is therefore a valuable index for the in vivo assessment 
of mitochondrial respiratory function by 31P MRS. It has to be taken into 
account that mitochondrial respiration, in turn, is influenced by several factors, 
such as pH and inorganic phosphate concentrations, as well as enzyme 
concentrations (Walsh et al., 2002). 
3.4 Objectives
The goal of the second part of this thesis was to develop an ergometer setup 
(Chapter 4) and quantification method for reliable and reproducible 
determination of metabolic parameters and phosphorus metabolite 
concentrations in vivo. Consequently, this setup should be applied to 
physiological studies (Chapters 5 & 6).
31P spectroscopy has a 100 times lower sensitivity than 1H spectroscopy and the 
investigation of dynamic metabolic changes require a sufficiently high temporal
resolution. Hence, the acquisition of average spectra form large volumes is 
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necessary to achieve a good SNR in a short amount of time. The use of a 
surface coil contributes to optimal SNR performance and is compatible with the 
ergometer setup. In the performed studies, no additional volume selection was 
performed and an adiabatic excitation pulse was used to further increase the 
SNR. Although attempts have been made to apply the ERETIC method (see 
Chapter 2) in combination with surface coils (Lee, 2007), a reliable 
quantification using this method depends on a homogeneous B1 field and a 
well-defined localization volume. Therefore, another quantification technique 
was applied, which was based on the use of ATP as an internal reference 
standard.
In a first study, the developed ergometer setup (see Chapter 4) and 
quantification approach was tested for its test - retest reproducibility.  It was 
subsequently used to assess the effect of physiological training (Chapter 5) and 
Diabetes Type 1 on muscle metabolism (Chapter 6) 
Chapter 4: Ergometer 71
Chapter 4:
DESIGN OF AN ERGOMETER SETUP 
FOR IN-VIVO MRS STUDIES OF 
SKELETAL MUSCLE METABOLISM
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4.1 Introduction
Magnetic resonance spectroscopy (MRS) has become a popular means to assess 
dynamic metabolic changes in skeletal muscle during exercise. 31P MRS allows 
for the measurement of cytosolic pH and the concentrations of ATP, 
phosphocreatine, and inorganic phosphate during exercise and recovery.
In order to study metabolism during muscle contractions in an MR scanner, 
ergometers have to be designed that are compatible with the unique field and 
material constraints which are imposed by the scanner and provide comfortable 
positioning and good fixation of the subjects. Several measurement setups have 
been constructed for the measurement of dynamic spectroscopic data during 
isometric contractions (Miller et al., 1988; Bangsbo et al., 1993; Raymer et al., 
2006). However, these ergometers are either limited in their ability to quantify 
forces, or visual feedback on the momentary contraction is not available. We 
have designed and constructed an MRS dynamometer for the measurement of 
muscular force during isometric contractions of the plantarflexor muscles 
against the pedal. Key features of the setup are a pedal with an integrated strain 
gauge, adjustment of ankle joint angle over the physiological range, leveling of 
dynamometer height, and real-time visual feedback for subjects on maximal 
voluntary contraction (MVC) during contractions. To account for the specific 
design and material constraints imposed by the magnetic field, non-magnetic 
materials were used and force values were transmitted optically. Using this 
setup, we have been able to follow inorganic phosphate an phosphocreatine 
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time courses as well as pH changes during isometric contractions at targeted 
MVC levels. 
4.2 Materials and Methods
The ergometer is designed to fit into a standard 3T Philips Achieva whole-body 
MR scanner (Philips Healthcare, Best, the Netherlands). 
The ergometer setup has to fulfill several requirements: (1) A good fixation of 
the subject’s leg and foot is needed in order to minimize movements and 
compensatory force production upon exhaustion, (2) the shoulders must be 
fixed with a device that can be adjusted to the subject’s height, (3) accurate 
force measurement and (4) a visual feedback for the volunteer is required so 
that a specific target force over time can be maintained, (5) a scanning software 
needs to be available which allows for triggering of the measurement, (6) and 
the foot angle needs to be freely adjustable within the physiological range to 
optimally address a specific target muscle group. (7) In addition, the 
measurement setup has to be MR compatible. 
MR compatibility
The frame of the pedal is made from polyvinyl chloride (PVC), and Plexiglas®
and Ertalite® were used for the foot holder. A support was built on which the 
pedal is held in a central position to enable measurements in the iso-center of 
the scanner, while still leaving enough space for comfortable positioning of the 
second leg. The support is made from aluminum for better stability- it was 
assured that the distance from the measurement coil was far enough so that the 
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occurrence of artifacts could be excluded. The entire support is screwed onto 
the scanner bed.
Ertalite® screws are mounted to the side of the pedal holder to allow an easy 
adjustment of the foot angle. The angulation of the ankle can be adjusted from 
70-120 degrees in steps of 5 degrees. A custom built, MR-safe strain gauge
(ETH Zurich, Sensory-Motor Systems Lab, Zurich, Switzerland) is positioned 
behind the foot plate and measures the force produced by the plantarflexor 
muscles. It contains an optical link to transmit the signal to a fMRI software 
(Presentation®, Neurobehavioral Systems, USA). The optical link guarantees a 
reliable force signal transmission throughout the scan.
The dynamometer is freely adjustable in height to account for the foot size. The 
ergometer is placed in the iso-center of the bore so that either the left or the 
right leg can be measured. The non-exercising leg can be comfortably placed 
beside the ergometer.
Fixation
A photograph of the fixation and placement of the volunteer with the MR-
compatible ergometer is shown in Figure 14. Velcro® straps are used to fasten 
the foot onto the footplate. The foot angle can be adjusted for any measurement 
and the straps guarantee identical joint angles during the measurement. A 
Plexiglas® plate with a wide leg strap is placed under the upper leg to tighten it 
to the measurement table. It provides a good fixation of the leg during muscle 
contraction and prohibits leg movements during the scan. The position of the 
Plexiglas® plate on the scanner bed can be freely adjusted using Ertalite®
screws and bars inserted into the narrow channels present at the edge of the 
scanner bed.  
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A Plexiglas® shoulder and head support was built to prevent movements of the 
volunteer in the longitudinal direction of the scanner. Cushions above the 
shoulders and beneath the head provide comfortable positioning for the subject. 
A mirror is placed above the head and shoulder support so that the subject can 
see the exerted force value and general instructions which are displayed on a 
screen inside the scanner room. 
Figure 14 Photograph of the MR-compatible ergometer with the leg and foot 
straps, head and shoulder support, and the optical cable (red) leading to the 
console room.
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a b
c
Figure 15 Computer assisted design (CAD) drawings of the ergometer setup. 
(a) View from the side, where the holes for the adjustment of the angulation can 
be seen. (b) View from the front. The holder for the ankle is shown in green, 
and two straps are then used to secure the foot. (c) Placement of the pedal on 
the scanner board. Aluminum bars (purple) are used for a rigid fixation of the 
pedal.
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Software
The measured force value is transmitted to an fMRI software (Presentation®, 
Presentation, Neurobehavioral Systems, USA), which converts the absolute
force values to relative MVC levels. The exerted force level and a target level 
are then displayed to the subject. Through the visual feedback on MVC, it is 
guaranteed that all subjects will apply the same percentage of their MVC for a 
given measurement. Importantly, this enables a standardization of the exercise 
protocol. 
The Presentation® software is triggered by the scanner so that a specific number 
of spectra can be acquired before the dynamic scan and the display start. If the 
target force level cannot be maintained for a continuous period of 5 seconds, 
the display of the target force level is turned off and the exercise is stopped. 
Measurements
Positioning of the subject begins by securing the heel in the foot holder and 
fastening the foot using two Velcro® straps. The 31P spectroscopy surface coil is 
then placed under the lower leg of the subject before the upper leg is fastened 
onto the Plexiglas® plate. Subsequently, the head and shoulders are fixated. The 
subject then exerts a single contraction against the pedal to determine the 
maximal voluntary contraction force. A certain percentage of this value (70-
85%) of this value is then used as target force for the actual spectroscopic 
measurement. For the acquisition of the spectra, a non-localized excitation is
performed using an adiabatic excitation in a pulse-acquire scheme (TR = 1.5s).
Twenty spectra are acquired in resting state before the start of the Presentation®
software is triggered. The target force level is displayed to the subject and has 
to be rapidly reached. If the subject is unable to maintain the target force level 
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and does not reach it again within 5 seconds, the display is turned off and the 
subject is told to stop the contraction so that the recovery of the metabolite 
concentrations and pH values can be followed. The reliability of the setup was 
tested in a study using nine female volunteers. Subjects were measured in two 
dynamic scans, one with a target force of 85% MVC for 30s and one with a 
target force of 70% MVC for 120s. Re-test measurements were performed for 
each subject on different days. 
Spectral postprocessing. All free-induction decays (FIDs) were zero-filled to 
4096 points, line-broadened with 6 Hz and Fourier-transformed into spectra. 
We used tdfdfit software (Slotboom et al., 1998) for fitting the line-shapes and 
integrating the metabolite peak areas and calculated inorganic phosphate (Pi)
and phosphocreatine (PCr) concentrations using the PCr/ATP and the Pi/ATP 
ratios. A concentration of 8.2 mM was assumed for ATP (Arnold et al., 1984; 
Kemp & Radda, 1994).
4.3 Results
All subjects reported that they were comfortable within the scanner at rest. One 
subject reported a minor discomfort in the shoulder region during heavy 
exercise, which was ameliorated using thicker cushions. There was adequate 
room for the non-exercising leg. 
The acquired spectroscopy scans showed a nice decrease in PCr and recovery 
of Pi and PCr concentrations could be easily followed (Figure 16). The exerted 
force as well as dynamic changes of metabolic parameters can be accurately 
determined for both lower legs.
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Figure 16 Phosphorus spectrum acquired with the above setup. The volunteer 
had to press at 85% of his maximal voluntary contraction for 30s (b) after the 
acquisition of 20 baseline scans (a). Phosphocreatine [PCr] recovery (c) was 
subsequently measured.
A good standardization of the measurements could be reached, as can be seen 
by a similar phosphocreatine, inorganic phosphate and pH curves in the test and 
re-test measurements (Figure 17) that were performed on different days.
a b c
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Figure 17 Time curves for the inorganic phosphate (top), pH (middle) and 
phosphocreatine (bottom) in the 30s (left) and 120s exercise (right) for the 
test (blue) and re-test (red) measurements.
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4.4 Discussion
We have described a MR-compatible exercise ergometer setup with a visual 
force feedback that is well suited for the measurement of metabolic parameters 
during isometric contractions. The ergometer setup provides the basis for the 
acquisition of well-standardized spectroscopy scans during exercise. 
Standardization is an important issue for the acquisition of dynamic 
spectroscopy scans since the changes in metabolite concentrations scale with 
the exercise intensity.
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Chapter 5:
EFFECTS OF TRAINING UNDER 
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5.1 Introduction
Phosphorus spectroscopy is a valuable tool for studying muscle metabolism 
non-invasively. Resting metabolite concentrations as well as dynamic changes 
of important metabolites that are involved in energy metabolism can be 
observed. To assess functional and metabolic changes that occur after a newly 
developed ischemic exercise training paradigm, in this study, 31P MRS data was 
analyzed. 12 healthy females (INT) were trained for five weeks on a vibration 
plate under ischemic conditions. Before and after the training period, metabolic 
parameters were assessed using phosphorus magnetic resonance spectroscopy 
(31P MRS). Post-exercise phosphocreatine (PCr) recovery from isometric 
contractions at fixed force levels normalized to maximal force against a foot-
pedal was measured. In addition, time series data of pH, PCr and inorganic 
phosphate (Pi) during isometric contraction were obtained, and resting 
metabolite levels, pH, muscle fiber composition as well as body functions were 
derived. Nine healthy female controls (CON) matched for age, activity level 
and BMI performed test and retest measurements without training. 
Elevated resting [Pi] (brackets denote concentration) levels were measured after 
five weeks of ischemic training. Also, significant increases of Pi were observed 
during isometric contractions at long contraction times. Increases in 
capillarisation as measured with muscle biopsies, stronger maximal forces, and 
increases in muscle volume show further adaptations to ischemic training. The 
increase in inorganic phosphate concentration at rest likely indicates a shift in 
muscle fiber type composition towards more oxidative fibers, whereas the 
increase in Pi during exercise may serve as a modulator of oxidative 
metabolism inside the muscle cells.
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Inorganic phosphate is a prerequisite for oxidative phosphorylation in the 
mitochondria, where it is used to form adenosine triphosphate (ATP). In 
addition, Pi plays an important role as a buffering agent and in the regulation of 
metabolic pathways in muscle cells (Walsh et al., 2002), such as glycolysis 
(Khoja, 1986; Rush & Spriet, 2001). 
In previous 31P studies, increases in [Pi] have been observed in mitochondrial 
cytopathies (Chance et al., 2006), with cast immobilization (Pathare et al., 
2005), in ischemic conditions in the myocard (Allen & Orchard, 1987), and in 
muscle of chicken following ischemia (Klabunde & Mayer, 1979). However, 
the mechanisms that lead to changes in [Pi] and its regulatory functions in vivo 
are still not completely understood. Regulatory effects of increased [Pi] include 
the enhancement of NADH generation (Bose et al., 2003), swelling of 
mitochondria in the presence of substrate (Anagnosti & Tedeschi, 1970; Izzard 
& Tedeschi, 1973; Halestrap, 1994), decreases in the mitochondrial Mg2+
concentrations (Garlid, 1980; Gunter et al., 1988; Jung et al., 1990), and 
activation of glycolytic enzymes (Khoja, 1986; Rush & Spriet, 2001). 
In addition, mitochondrial respiration is influenced by changes in inorganic 
phosphate concentrations. Mitochondrial respiration is an important metabolic 
process where the driving power (proton motive force) for ATP production is 
generated. Electrons are transported through an electron transport chain onto 
molecular oxygen. A modulatory effect of Pi on mitochondrial creatine kinase 
(CK), a key enzyme involved in mitochondrial respiration, has been reported as 
early as 1979 (Vial et al., 1979). Further work on isolated heart mitochondria 
(Mukherjee et al., 1980; Hall & Deluca, 1984), skinned cardiac fibers  (Veksler 
& Ventura-Clapier, 1994) and soleus muscle fibers (Walsh et al., 2002) have 
demonstrated that in vitro, concentrations in Pi up to 5 mM increase the 
maximal rate mitochondrial respiration, but when [Pi] exceeds 5 mM, CK starts 
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to dissociate from the inner mitochondrial membrane and the rate of respiration 
in presence of creatine decreases. This decrease is likely caused by longer 
diffusion paths of ATP before it reaches the CK (Hall & Deluca, 1984).
Following the above in vitro experiments, it has been hypothesized that 
increases in  [Pi] at low concentrations may be the primary feedback signal for 
stimulation of oxidative phosphorylation in the heart muscle in vivo at different 
workloads (Wu et al., 2008), while the primary role for stimulation of oxidative 
phosphorylation has been assigned to adenosine di-phosphate (ADP) in skeletal 
muscle (Balaban, 1990; Brown, 1992). 
Resting Pi concentrations in skeletal muscle remain at levels around 3-6 mM 
(Chance et al., 2006) depending on the fiber type composition of the muscle 
(Kushmerick et al., 1992; Takahashi et al., 1996). During high-intensity 
exercise, [Pi] can increase to concentrations well above 20 mM (Sahlin et al., 
1997). At such elevated concentrations, Pi induces concentration-dependent 
reductions in mitochondrial respiration in isolated soleus muscle fibers (Walsh
et al., 2002), as was determined by polargraphic measurements.
Measuring a number of key energy metabolites in vivo is possible using 31P
magnetic resonance spectroscopy (MRS), in which signals from 
phosphocreatine, adenosine tri-phosphate (ATP) and inorganic phosphate, as 
well as intracellular pH are quantifiable from measured spectral intensities. 
While saturation transfer experiments for the measurement of CK flux only 
access a small proportion of the total CK (van Deursen et al., 1994; Wallimann, 
1996), stimulation-recovery experiments allow for the assessment of full 
mitochondrial CK functionality through the recovery curve of the PCr that is 
resynthesized by the enzyme. Phosphocreatine resynthesis after exercise 
depends on oxidative ATP synthesis (Sahlin, 1978; Taylor et al., 1983) and 
therefore provides information about the mitochondrial function. However, 
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many factors can influence the phosphocreatine resynthesis rate. A strong
correlation of >PCr with the intracellular pH after exercise has been shown in 
many studies ((van den Broek et al., 2007) and references cited therein), while 
the direct effects of low pH on mitochondrial respiratory rates remain 
unknown. Reports range from inhibition (Harkema & Meyer, 1997; Walsh et 
al., 2002) to increased respiratory rates (Connett, 1988; Funk et al., 1990). In 
addition to a correlation of >PCr with pH, several reports have shown a 
correlation of the end-exercise Pi concentrations with >PCr (i.e. (Kemp et al., 
1993)).
In this study, we correlate the PCr recovery constants with pH and [Pi] at the 
end of isometric contractions before and after five weeks of ischemic training. 
31P MRS, magnetic resonance imaging (MRI), dual X-ray absorptiometry 
(DXA) and muscle cell assays are used to assess muscle metabolism at rest.
5.2 Research Design and Methods 
Subjects
We recruited 21 sedentary young women and randomly assigned them to two 
groups. Twelve healthy (asymptomatic) females were assigned to an 
intervention group (INT). Nine healthy subjects matched for age, BMI, and 
activity level were recruited in a control (CON) group. A higher number of 
subjects was assigned to the INT group because of a higher risk for study 
dropouts. All subjects were untrained with physical activity of less than half an 
hour twice a week. Nine and seven women in INT and CON, respectively, were 
taking oral contraceptives. Physiological parameters are listed in Table 4. After 
completing a routine health questionnaire, the participants were informed about 
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the procedures applied and about the associated risks. The participants then
signed an informed consent. All experiments were approved by the ethics 
committee of the canton of Zurich. The study was performed in accordance 
with the ethical standards laid down in the Declaration of Helsinki for human 
experimentation.
INT CON
Age (Y) 23.5 ± 3.0 24.5 ± 3.8
Body Height (m) 1.68 ± 0.06 1.68 ± 0.07
Body Weight (kg) 61.0 ± 8.2 60.7 ± 5.4
Table 4 Characteristics of subjects in the intervention and control groups
Study design and exercise protocol
The study consisted of 1) baseline measurements (subsequently labelled PRE); 
2) five weeks of progressive exercise for INT or a similar period without 
exercise for CON; and 3) post-intervention measurements (labelled POST). The 
exercise regimen was designed according to the recommendations of (Toigo & 
Boutellier, 2006). During the study, macronutrient intake was not monitored, 
and participants were not given any food or dietary supplements. 
Baseline measurements. We performed baseline measurements to assess resting 
metabolite levels, PCr, Pi and pH time curves during isometric contractions, 
task-specific strength, calf lean mass and capillary to fiber ratio. Participants 
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were familiarized with the training and/or strength testing procedures on two 
separate occasions before the actual measurements. 
Training protocol. A detailed description of the training protocol is given 
elsewhere (Toigo et al., 2010). In brief, participants of the INT group 
performed three supervised progressive training sessions per week on alternate 
days for five weeks (16 training sessions), followed by three training sessions 
with the same load as during the last progressive training session. 
A warm-up phase was followed by six sets of resistance exercise with both, 
superimposed vibration exercise and vascular occlusion: Three sets of loaded 
(Multipower®, Technogym, Gambettola, Italy) squats were performed while 
standing on a Galileo® side-alternating vibration platform (Novotec, 
Pforzheim, Germany) (Rittweger et al., 2001) oscillating at 30 Hz. These were
followed by three sets of loaded heel rises on the vibration platform which 
alternated between sessions as follows: 2 sets of heel rises while standing and 1 
set of seated heel rises or vice versa. For both, squat and heel rise exercise a set 
of 4 min on and 1 min off was employed, whereas between squats and heel 
rises, participants rested for 5 min. Vascular occlusion during the exercise was 
induced by inflating tourniquet cuffs (VBM, Sulz a.N., Germany) to 
suprasystolic pressure, i.e. 197 (3) mmHg [SI: 26.26 (0.40)·10 3 Pa]. The cuffs 
were affixed to the inguinal fold region of the thigh, or to the proximal portion 
of the lower leg, centered in the space between the superior aspect of the 
gastrocnemius muscle and the inferior edge of the patella. For both, squat and 
heel rise exercise, tourniquet cuffs were inflated right before the first set and 
remained inflated until the 4 min of vascular occlusion were complete. The 
cuffs were then deflated to a pressure of 100 mmHg (SI: 13.33·103 Pa), and the 
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participants rested for 1 min before the cuffs were quickly reinflated for the 
subsequent set.
Post-intervention measurements
The post-intervention measurements were identical in all respects to the 
baseline measurements.
Magnetic Resonance Spectroscopy
Dynamic 31P magnetic resonance spectroscopy (31P-MRS) scans were acquired 
during isometric muscle contraction using a 3 Tesla whole body Philips 
Achieva Scanner (Philips Healthcare, Best, The Netherlands). For this purpose, 
we designed an MRS-compatible ergometer setup (Heinzer-Schweizer et al., 
2009), which was comprised of a dynamometer with an integrated strain gauge 
(Sensory-Motor Lab, ETH Zurich, Switzerland) for force measurements (see
Figure 14), a real-time visual feedback system providing the participants with 
information on the level of exerted force relative to maximal voluntary force, 
and an appropriate fixation of the leg and body. Presentation® software 
(www.neurobs.com) was used for the implementation of a visual feedback 
system and the display was triggered using the scanner software. During the 
measurements, the participants lay supine on the scanner bed with their non-
dominant leg in the centre of the scanner bore. We fastened the foot of the leg 
to be measured onto the foot holder at an angle of 100° plantarflexion using 
Velcro® straps. The exercising leg was held in place with a 0.06 m wide strap 
above the knee to minimize any quadriceps muscle force contribution. The 
knee of the exercising leg was almost fully extended (170°) to allow near-
physiological conditions for calf muscle exercise (Quistorff et al., 1990). 
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A transmit/receive surface coil (diameter: 14 cm) tuned to 51.8 MHz was 
placed under the participant's calf and fastened with a Velcro® strap. This way, 
the field of view (FOV) of the coil included signal from the triceps surae 
muscles with the main contribution stemming from the gastrocnemius muscle. 
Prior to the isometric contraction experiment in the magnet, each participant 
was familiarized with the setup. After the practice session, images of the lower 
leg were acquired at rest, covering an area from the knee to the ankle. 60 slices 
of these localizer images were collected using the body coil of the scanner in a 
turbo-spin echo (TSE) sequence (echo time TE = 6.95 ms, repetition time TR = 
399 ms, slice thickness = 6 mm, field of view FOV = 162x162 mm) in 3 stacks 
to ensure magnetic field homogeneity over the entire volume. 
Following the imaging session, the participants performed a single maximal 
voluntary plantarflexion attempt against the fixed dynamometer pedal, and we 
measured the maximal force acting on the pedal (MVFP). 31P-MRS spectra of 
the triceps surae muscles were acquired using a pulse-acquire technique and an 
adiabatic hyperbolic secant excitation pulse. A 2nd order FASTERMAP 
(Gruetter, 1993; Shen et al., 1997) volume shim was applied, and the shim 
volume was optimized so that bones and fat were excluded from the shim 
procedure. After acquisition of a fully relaxed spectrum at rest (20 averages, 
TR = 16s, 5 dummy scans, 2048 sample points), the participants performed 1 
isometric plantarflexion at 85% MVFP – subsequently labeled bout 1 - for 30 s 
(five dummy scans, 20 spectra before the exercise for saturation correction, TR 
= 1.5 s and three signal averages per time point, leading to a temporal 
resolution of 4.5 s). After that, participants were allowed to recover in the fixed 
position for 20 min before performing an isometric plantarflexion at 70% 
MVFP until exhaustion or at maximum for 120 s, denoted as bout 2 in the 
following text (five dummy scans, TR = 1.5 s and three signal averages per 
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time point). If the volunteer was not able to reach the required force level for a 
continuous time of more than five seconds, the display of the visual feedback 
was stopped and the subject was told to discontinue the contraction so that the 
recovery period could be followed. Recovery spectra were measured after 
exercise cessation for 324 (plantarflexion at 85% MVFP) and 264 seconds 
(plantarflexion at 70% MVFP). After both plantarflexion efforts, perceived 
exertion was rated according to a modified Borg scale from 0 to 10 (Wilson & 
Jones, 1991a). Two different dynamic spectroscopy measurements were chosen 
to monitor the changes at various time-scales and close to the maximal 
performance (85% and 70% MVFP) of the subjects at different pH levels.
Image processing. The TSE images were segmented using GTVolume 
Software (Gyrotools Ltd., Winterthur, Switzerland) before the volume of 
muscle and fat content was evaluated in the same region as for the DXA scans 
(see below).
Spectral processing. All free-induction decays (FIDs) were zero-filled to 4096
points, line-broadened with 6 Hz and Fourier-transformed into spectra. We 
used tdfdfit software (Slotboom et al., 1998) for fitting the line-shapes and 
integrating the metabolite peak areas. 12 lines were included in the fit model, 
one line each for Pi, monoester, diester, PCr, and a baseline component, and 
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.ATP. The spectrum was then 
fitted as a sum of basic mathematical model functions (Voigt lines).
Inorganic phosphate (Pi) and phosphocreatine (PCr) concentrations were 
calculating using the PCr/ATP and the Pi/ATP ratios, respectively. To this end, 
a concentration of 8.2 mM was assumed for ATP (Arnold et al., 1984; Kemp & 
Radda, 1994). The saturation factor in the dynamic spectra was determined by 
Chapter 5: 31P MRS: Exercise Study 93
the ratio of the relaxed spectra to the partially saturated spectra acquired prior 
to the plantarflexion exercise. 
Calculations. We calculated the PCr recovery rate using a mono-exponential
fitting procedure (Iotti et al., 1993). Intracellular pH-values were calculated 
from the chemical shift of Pi according to the modified Henderson-Hasselbalch 
equation (Petroff et al., 1988).
Exclusion criteria. Rigorous quality criteria were applied to the spectra. We 
excluded all spectra of a volunteer acquired under exercise conditions from the
analysis if the PCr decrease after bout 1 was below 25%. In these cases, it was 
improbable that the initial calibration of MVFP was correct. PRE and POST 
spectra of those volunteers were excluded. This led to the exlusion of 4 
volunteers, all of which were part of the INT group.
For the image segmentation, all but one dataset could be used. In the excluded 
dataset, there were movement artifacts so that the image segmentation was 
imperfect. Two data values of the perceived exertion and one data point of 
MVFP were lost.
Muscle Biopsy analyses
Biopsies were conducted according to the protocol described in detail in (Toigo
et al., 2010). In brief, a percutaneous biopsy was obtained after local 
anaesthesia from the nondominant soleus muscle several days before the start 
of the first training session and after the last training session. The muscle tissue 
was immediately mounted in an embedding medium (Tissue-Tek, Sakura, 
Zoeterwoude, The Netherlands) after its removal and was then snap frozen in 
isopentane cooled to ?52@A%	"/	A
	5m sections 
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were cut on a microtome at ?, @A  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further histochemical and immunohistochemical analyses. 
For all fiber analyses, only fibers fully encircled by adjacent fibers were 
evaluated, and measurements were made for at least 50 of each of the main 
fiber types (i.e. myosin heavy chain [MyHC] isoform type I and II).
Serial cryocut cross-sections were stained using the myofibrillar adenosine 
triphosphatase (mATPase) method (Guth & Samaha, 1970), with minor 
modifications (Muntener, 1979). Fiber cross-sectional areas were estimated 
from the lesser fiber diameter method (Dubowitz & M., 1985). For the 
determination of muscle capillarisation, consecutive cryocut sections were 
fixed with acetone for 10 min at 4 °C and exposed to the monoclonal mouse 
anti-human CD31 endothelial cell antibody (DAKO, Carpinteria, Canada, 
1:600 dilution), which acts as a marker for muscle capillaries. As a control,
samples without the addition of an antibody were prepared. There, the antibody 
was replaced with Tris-buffered saline (TBS) buffer. The overall capillary-to-
fiber ratio was calculated by dividing the number of CD31-positive cells by the 
number of muscle fibers. The sample quality of 8 INT and 5 CON volunteers 
was sufficient for analysis, i.e. contained more than 50 fibers. 50 fibers are 
necessary for a reliable, valid representation of an individual's average fiber 
area and capillary-to-fiber ratio (McCall et al., 1998; Porter et al., 2002).
Dual-energy X-ray absorptiometry 
To determine the muscle mass of both calfs, a dual X-ray absorptiometry 
(DXA) machine (Lunar iDXA™, GE Healthcare, Madison, WI, USA) was used 
according to the manufacturer’s specifications. All total body scans were 
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conducted in the standard (0.13–0.25 m) mode. Segmental scan analysis were 
performed using the GE encore software version 11.40.004, using the total 
body bone and tissue scan images to delineate the regions of interest (ROI) as 
follows: ROI upper boundary: line through the femoral neck parallel to the 
inguinal ligament; lower boundary: horizontal line between femur and tibia; 
lateral boundaries: outer leg cuts. 
Statistical analyses
Data are presented as mean ± standard deviation (SD). According to guidelines 
provided by the statistics helpdesk at University Zurich, group differences 
between INT and CON were tested for statistical significance by repeated 
measures ANOVAS with posthoc paired t-tests. The training status (CON, 
INT) was defined as between-subject covariate for the ANOVA analysis. The 
level of significance was set to P < 0.05. For all statistical analyses SPSS 16.0 
statistical software (SPSS, Chicago, USA) was used.
5.3 Results
The effects of ischemic training on resting metabolite levels, functional and 
metabolic changes induced in muscle in the resting state are listed in
Table 5. [Pi] increased by slightly more than 1 mM from 4.7±0.8 mM to 
5.9±1.1 mM (+27%, F = 19.732, p < 0.001). The resting pH was significantly 
increased in a paired t-test in the INT group after training (p< 0.05), however, it 
did not reach significance in a repeated measures ANOVA (F = 3.161, p= 
0.09). Resting [PCr] did not change.
The fat mass of the muscle determined by DXA did not change, however a
significant increase in the muscle volume (calf lean mass, +6%, F = 16.957, p <
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0.001) was observed. Similar results were observed when muscle volume was 
assessed using magnetic resonance imaging, MRI (+6%, F = 6.616, p < 0.05). 
In addition to muscle volume growth, the perfusion was ameliorated, which 
was evident from an increased capillary-to-fiber ratio (+14%, F = 15.731, p < 
0.01). No differences were found between test and re-test measurements for the 
muscle fiber diameter and cross-section (CS).
The maximal force measured with the dynamometer at the scanner (MVFP) was 
significantly increased in the INT group based on a paired t-test, but it did not 
reach significance in a repeated measures ANOVA (F = 3.866, p=0.069). The 
perceived strain (Borg rating) remained unchanged. No changes were found in 
the VO2max determined in a cycling ergometer test (Toigo et al., 2010). Figure 
18 displays clustered box plots of the observed changes. 
Table 6 lists the dynamic changes that were observed during isometric exercise 
inside the MR scanner. [Pi] after bout 2 is significantly increased in the INT 
group (+32%, F = 7.708, p= 0.05) in the INT group after training. 
End-exercise pH values differed for bout 1 in a paired ttest (p < 0.005), 
however no changes were found in a repeated measures ANOVA and this 
change did not show up when the lowest pH was reached in bout 1 nor did it 
persist for the longer lasting isometric muscle contraction in bout 2. repeated 
measures ANOVA test. 
Test- retest time courses of the [Pi], pH and [PCr] of the CON group are 
displayed in Figure 19, indicating a high reproducibility of the measurements. 
Correlation curves for pH and Pi versus >PCr are plotted in Figure 20. The large 
majority of points lies inside the confidence interval.
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INT CON
PRE POST PRE POST
Calf fat mass (g) 868 ± 212 (12) 856 ± 210(12) 788 ± 89(9) 779 ± 83(9)
Calf lean mass (g) 1700 ± 264(12) 1803 ± 275**(12) 1690 ± 225(9) 1691 ± 206(9)
MRI fat volume 
(mm3)
2808 ± 676(11) 2825 ± 657(11) 2885 ± 371(9) 2843 ± 361(9)
MRI Muscle 
Volume (mm3)
7249 ± 858(11) 7653 ± 774**(11) 7221 ± 731(9) 7262 ± 625(9)
Capillary-to-fiber
ratio 
1.8 ± 0.4(9) 2.1 ± 0.5**(9) 1.8 ± 0.3(6) 1.8 ± 0.2(6)
Muscle fiber diameter 
)m)
58.4 ± 8.4(8) 58.0 ± 7.5(8) 52.3 ± 3.7(5) 56.9 ± 5.8(5)
Muscle fiber CS 
)2)
2726 ± 761(8) 2677 ± 675(8) 2157 ± 298(5) 2559 ± 531(5)
Resting pH 7.03 ± 0.01(12) 7.05 ± 0.02(12) 7.02 ± 0.02(9) 7.03 ± 0.02(9)
Resting [Pi] (mM) 4.6 ± 0.8(12) 5.9 ± 1.1**(12) 4.9 ± 0.5(9) 4.4 ± 0.6(9)
Resting [PCr] (mM) 37.5 ± 3.6(12) 39.5 ± 4.4(12) 36.8 ± 3.6(9) 37.8 ± 5.0(9)
Table 5. Metabolic and systemic parameters that were measured at rest in the 
INT and CON groups before and after five weeks of ischemic training. The 
number of valid samples is given in brackets. Parameters whose p-value was 
statistically significant in a paired t- test are marked in bold and denoted with * 
(p<0.05) or ** (p<0.005).Related F-values are given in the text.
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INT CON
PRE POST PRE POST
>PCr exercise bout 1(s)          30.4 ± 2.9(8) 36.9 ± 8.9(12) 37.1 ± 10.4(9) 40.2 ± 11.6(9)
>PCr exercise bout 2 (s) 44.2 ± 5.9(8) 47.9 ± 12.4(8) 48.9 ± 9.2(9) 47.1 ± 6.2(9)
End-exercise pH  bout 1 7.00 ± 0.04(8) 7.01 ± 0.04(8) 7.00 ± 0.05(9) 7.00 ± 0.04(9)
Lowest pH bout 1 6.94 ± 0.06(8) 6.90 ± 0.05**(8) 6.88 ± 0.05(9) 6.87 ± 0.07(9)
End-exercise pH  bout 2 6.78 ± 0.14(8) 6.79 ± 0.13(8) 6.82 ± 0.09(9) 6.82 ± 0.14(9)
Lowest pH bout 2 6.64 ± 0.20(8) 6.63 ± 0.14(8) 6.63 ± 0.17(9) 6.64 ± 0.15(9)
End-exercise [Pi] bout 
1(mM)
16.2 ± 5.1(8) 18.2 ± 3.6(8) 17.5 ± 5.3(9) 19.4 ± 5.1(9)
End-exercise [Pi] bout 2 
(mM)
25.0 ± 5.7(8) 33.0 ± 3.0*(8) 26.9 ± 5.6(9) 26.5 ± 5.4(9)
End-exercise [PCr] bout 1 
(mM)
21.6 ± 5.4(8) 20.5 ± 4.6(8) 17.8 ± 3.9 (9) 18.1 ± 4.6 (9)
End-exercise [PCr] bout 2
(mM)
9.1 ± 5.2(8) 7.6 ± 3.5(8) 7.9 ± 3.5 (9) 7.9 ± 3.5 (9)
Borg Rating bout 1 7.79 ± 1.78(7) 8.21 ± 1.91(7) 8.25 ± 0.96(8) 8.19 ± 0.92(8)
Borg Rating bout 2 9.36 ± 0.94(7) 9.29 ± 1.11(7) 9.38 ± 0.74(8) 9.75 ± 0.46(8)
MVFP (W) 517 ± 92(7) 595 ± 78*(7) 588 ± 112(9) 606 ± 99(9)
Table 6. PCr recovery k-values, changes in metabolite levels and pH during 
exercise and Borg ratings for the 30s and 120s exercise paradigms. Values that 
were significant in a paired t-test are denoted with * (p<0.05) or ** (p<0.005).
The number of valid samples is given in brackets. F-values are given in the text.
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Figure 18 Systemic and metabolic adaptations to training: PRE and POST 
measurements are shown for the INT (red) and CON (blue) groups for 
inorganic phosphate (a), MVFP (b), capillary-to-fiber ratio (c) and calf lean 
mass (1d).
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Figure 19 Time courses of the PRE (blue) and POST (red) measurements are 
shown for the CON group. Row 1 displays the [Pi],and row 2 the [PCr] time 
course, while row c displays the pH time course of bout 1 (left) and bout2 
(right). PRE- and POST measurements of all volunteers who were able to 
maintain the contraction force for the entire exercise duration (6 volunteers 
for bout 2) are shown, indicating a high reproducibility of the measurements.
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Figure 20 Results of the linear regression analysis of 'PCr versus end-exercise 
pH (a) and end-exercise [Pi] (b) for all experimental data. A correlation can 
be seen for all parameters. A better correlation is reached for the lowest pH 
that is reached after the end of the exercise bouts than for the end-exercise 
pH.
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5.4 Discussion and Conclusion
Study results. The results indicate that repetitive ischemic strength training 
increases the resting concentrations of Pi as well as the [Pi] during exercise. A 
higher resting [Pi] has been observed in muscle with a higher fiber type 1 
content (Kushmerick et al., 1992; Takahashi et al., 1996). In addition, in 
muscle biopsies that have been obtained from the same INT subjects in the 
vastus lateralis muscle, a shift towards more oxidative type 1 fibers was 
observed (Toigo et al., 2010). Vastus lateralis muscle has a similar fiber type 
composition as the gastrocnemius muscle (Spurway & Wackerhage, 2006) and 
similar training effects may be expected. For the lower leg, muscle fiber types 
were not determined. No changes were expected to be seen in the soleus 
muscle, which contains approximately 80% type 1 fibers.
The muscle fiber type dependence of resting [Pi] might be assigned to different 
buffer capacities, as Pi is one of the key pH buffers, or to its function as an 
activator of glycolytic enzymes (Khoja, 1986; Rush & Spriet, 2001). However, 
increasing concentrations of Pi also seem to induce a gradual dissociation of 
CK from the inner mitochondrial membrane (Vial et al., 1979; Veksler & 
Ventura-Clapier, 1994; Walsh et al., 2002; Wu et al., 2008) and result in a 
decrease in post-ADP state 4 respiration in the presence of creatine in isolated 
mitochondria (Hall & Deluca, 1984). These results suggest that the 
concentration of inorganic phosphate in vivo serves to regulate the rate of PCr 
repletion. In the PRE measurements, a higher MVFP was measured in the CON 
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group, while the INT group only reached this value in the POST measurement 
(Figure 18c). Thus the higher end-exercise [Pi] in the INT group in bout 2 
(Table 6) may be due to a higher workload. However, the PCr depletion 
remained similar so that the increase in [Pi] is likely to be a consequence of the 
increased baseline [Pi] and thus a metabolic adaptation. 
Linear regression analysis (Figure 20+
%
""		>PCr with 
end-exercise [Pi] and end-exercise pH. B "	
  >PCr have been 
shown in other studies before with end-exercise Pi (i.e. (Kemp et al., 1993))
and with end-exercise pH (i.e. (Iotti et al., 1993; van den Broek et al., 2007)
and references cited therein). The points of the INT group in Figure 20 stay 
within the bounds of the confidence interval, so that no direct change of the 
oxidative metabolism is directly visible in these analyses. The influence of pH 
>PCr varies greatly among subjects from around 33 s/pH unit to more than 
75s/pH unit (van den Broek et al., 2007), so that a correction of k for pH is not 
appropriate. The differences in the linear correlation may be due to unequal 
efflux rates in the individual subjects. In addition, the role of pH in the recovery 
of [PCr] remains unclear (van den Broek et al., 2007). Regulation of PCr 
resynthesis has been attributed to ADP (Kemp et al., 1993), and argumentation 
against a regulatory effect of [Pi] was given in the low Michaelis constant of 
approximately 1mM, which is below the measured resting concentration of Pi
and therefore makes the control of respiration through Pi unlikely (Chance et 
al., 1985). However, in this argumentation, the hypothesis of CK dissociation at 
high Pi concentrations (Vial et al., 1979; Hall & Deluca, 1984; Walsh et al., 
2002) is not considered. 
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The lower minimal pH that has been observed in bout 1 in the INT group after 
training is probably the consequence of a higher exerted force and therefore a 
higher workload. The change is small, and it remains difficult to resolve its 
physiological impact. 
Other changes that have been observed in this study include increases in 
measured force and muscle diameter. They represent common adaptations to 
strength training. The measured increase in capillary/fiber ratio most likely 
occurs as an adaptation to ischemic exercise training. It might be a 
compensation reaction that increases the oxygen storage capacities inside the 
muscle for the case of transient ischemia. Increased capillarization has been 
similarly observed in peripheral vascular disease (Hammarsten et al., 1980; 
McGuigan et al., 2001). 
Possible limitations of the study. When interpreting data from training 
paradigms, the muscle and/or fat volume may change, as was the case in this 
study. Such a change leads to different measurement volumes in repeated 
measurements. In this study, the muscle volume in the INT group increased, 
while the fat volume remained the same. This indicates that the measured 
proportion of fat vs. muscle volume did not change. However, different 
proportions of the different triceps surae muscles may have contributed their 
signal to the spectrum. 
Since the calculation of the resting concentrations of Pi is based on the Pi/ATP 
ratio with the assumption of a constant ATP concentration of 8.2 mM (Arnold
et al., 1984; Kemp & Radda, 1994), one could infer a lower resting ATP 
concentration instead of a higher Pi concentration. However, resting ATP and 
PCr concentrations are generally well buffered and thus show little variance 
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across the populations (Kemp et al., 2007). They have been shown to remain 
unchanged after 8 weeks of sprint training (Nevill et al., 1989). Also, relative 
resting PCr/ATP ratios did not differ between trained and untrained groups in 
this study.
Therefore, an increase in resting Pi concentration after five weeks of ischemic 
training is plausible. It is unlikely that the rise in resting [Pi] is caused by other 
processes than a change in muscle fiber type composition, such as 
inflammation, since none of the subjects reported any muscle ache and the 
performance of the participants was ameliorated. 
In conclusion, changes in [Pi] at rest, which are likely to represent a shift in 
muscle fiber type composition, have been found. The increased Pi
concentrations persist during exercise. They are paralleled by an increase in 
muscle volume and capillary to fiber ratio. Together, these changes lead to an 
increase in peak power (Toigo et al., 2010).
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Chapter 6:
SKELETAL MUSCLE 
MITOCHONDRIAL OXIDATIVE 
FUNCTION AND CARDIO-
RESPIRATORY CAPACITY ARE 
NOT IMPAIRED IN PATIENTS WITH 
TYPE 1 DIABETES
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6.1 Introduction
Currently, there is a debate about the validity of the still widely accepted 
concept that muscle mitochondrial deficiency and/or dysfunction causes muscle 
insulin resistance which leads to diabetes (Lowell & Shulman, 2005; Holloszy, 
2009). In support of this concept, it has been reported, that genes involved in 
oxidative phosphorylation are downregulated (Mootha et al., 2003a), and that 
mitochondrial oxidative enzyme activity, mitochondrial size and content are 
reduced in patients with type 2 diabetes or in insulin-resistant offspring of 
patients with type 2 diabetes (He et al., 2001; Kelley, 2002). Accordingly, it 
has been hypothesized that mitochondrial deficiency/dysfunction impairs the 
ability of muscle to oxidize fatty acids, and leads to intramuscular lipid 
accumulation and insulin resistance (Kelley, 2002; Lowell & Shulman, 2005; 
Morino et al., 2006). In keeping with the concept that muscle mitochondrial 
dysfunction causes insulin resistance it has also been reported that men with 
type 1 diabetes have a reduced skeletal muscle oxidative capacity, as assessed 
by 31P magnetic resonance spectroscopy (31P-MRS) (Crowther et al., 2003b). 
However, there is also compelling evidence that mitochondrial function is not 
affected in patients with diabetes. A recently published ex vivo study has shown 
that when oxygen flux is normalized for mitochondrial content, oxidative 
phosphorylation and electron transport capacity in muscle extracts obtained 
from patients with type 2 diabetes are not different from a healthy control group
(Boushel et al., 2007). These findings are supported by a study on Asian 
Indians with type 2 diabetes, for whom the capacity for oxidative 
phosphorylation is similar to healthy controls (Nair 2008). Furthermore, in vivo
skeletal muscle oxidative function, assessed by 31P-MRS, has been shown to be 
similar between long-standing, insulin-treated type 2 diabetes patients, persons 
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with early stage type 2 diabetes, and healthy controls (De Feyter et al., 2008).
Taken together, at present, it is unclear whether skeletal muscle mitochondrial 
deficiency/dysfunction are a consequence of insulin resistance or are
instrumental in its development, or whether these factors manifest themselves 
at all in the insulin resistant state. In fact, Hollozsy (Holloszy, 2009) recently 
highlighted the latter point when he commented that even if mitochondrial 
content was reduced, skeletal muscle still would contain sufficient 
mitochondria to make possible a ~150-fold increase in oxygen consumption per 
kilogram of muscle under exercise conditions (Andersen & Saltin, 1985), and 
that it is therefore unlikely that an increase in intramyocellular lipid content and 
the resulting insulin resistance in patients with diabetes are the result of defects 
in the mitochondria at their basal state. 
In order to further shed light upon the relationship between oxidative 
metabolism and diabetes, we tested the hypothesis that there is no difference in 
myocellular and systemic markers of oxidative capacity between young women
with type 1 diabetes?a population for which no respective data is available 
yet?and healthy women of similar age and physical activity level. To this end, 
we compared the 31P-MRS-derived calf muscle end-exercise rates of oxidative 
ATP synthesis (i.e. mitochondrial capacity), muscle fiber metabolic phenotype
and capillarization, peak and submaximal values for oxygen consumption and 
cardiac output, as well as endurance capacity between the 2 groups. 
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6.2 Research Design and Methods
Participants
We recruited 9 sedentary young women with type 1 diabetes (DIA) and 29 
healthy women of similar age and activity level (CON). Mean age was 26.9 
(SD 5.2) years for DIA, and 24.1 (4.2) years for CON. The participants' 
anthropometric data are presented in Table 7. Patients with type 1 diabetes had 
no diabetic complications or coexisting cardiovascular diseases. The duration 
of diabetes was 13.1 (6.6) years, and mean total daily insulin doses were 41 
(13) units. The glycosylated haemoglobin A1c (HbA1c) was 7.6 (0.4) % (DIA) 
and 5.3 (0.2) % (CON) (P < 0.001). Participants in both groups displayed no 
metabolic risk factors according to Adult Treatment Panel III criteria 
(Wyszynski et al., 2005) (). Participants in the CON group were healthy 
(asymptomatic). They showed no sign of either impaired glucose tolerance, i.e. 
fasting glucose concentration: 4.49 (0.26) mmol·l-1, blood glucose 
concentration 2 h post glucose load: 4.92 (1.19) mmol·l-1 (Unwin et al., 2002)
or calculated insulin resistance [homeostasis model assessment
(HOMA,(Matthews et al., 1985)): 1.4 (0.4)]. All participants were untrained 
and physically active less than 1 hour per week. After completing a routine 
health questionnaire, the participants were informed about the applied 
procedures and the associated risks. Written consent was obtained from all 
participants. The experimental protocol was approved by the ethics committee 
of the canton of Zurich and the study was performed in accordance with the 
ethical standards laid down in the Declaration of Helsinki for human 
experimentation.
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Table 7 Anthropometric characteristics of study participants. 9 patients with 
type 1 diabetes (DIA) and 29 healthy controls (CON) participated in this study. 
Data are expressed as means and standard deviations (SD). * P < 0.05, ** P < 
0.01. The body mass index is the weight in kilograms divided by the square of 
the height in meters.
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Table 8 Cardiometabolic risk factors of study participants. Blood samples 
of 4 patients with type 1 diabetes (DIA) and of 21 healthy controls (CON) 
were available for analysis. Data are expressed as means and standard 
deviations (SD). None of the denoted cardiometabolic risk factors were 
statistically significant different between DIA and CON. HDL, high-density 
lipoprotein; Total-C, total cholesterol; hsCRP, high-sensitivity C-reactive 
protein.
Magnetic Resonance Spectroscopy
A detailed description of the magnetic resonance experiments is given in 
Chapter 5. In brief, dynamic 31P magnetic resonance spectroscopy (31P-MRS) 
scans were acquired during isometric muscle contraction using a 3 Tesla whole 
body Philips Achieva Scanner (Philips Healthcare, Best, The Netherlands). For 
this purpose, an MRS-compatible ergometer setup was used (Chapter 3). A 
visual force feedback was given to the volunteers using Presentation® software 
(www.neurobs.com). During the measurements, the participants lay supine on 
the scanner bed with their non-dominant leg in the centre of the scanner bore. 
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We fastened the foot of the leg to be measured onto the foot holder at an angle 
of 100° plantarflexion using Velcro® straps. 
A transmit/receive surface coil (diameter: 14 cm) tuned to 51.8 MHz was 
placed under the participant's calf and fastened with a Velcro® strap. Prior to 
the isometric contraction experiment in the magnet, each participant was 
familiarized with the setup in a training session. After the practice session, 
localizer images of the lower leg were acquired at rest, covering an area from 
the knee to the ankle. 
Following the imaging session, the participants performed a single maximal 
voluntary plantarflexion attempt against the fixed dynamometer pedal, and we 
measured the maximal force acting on the pedal (MVFP). 31P-MRS spectra of 
the triceps surae muscles were subsequently acquired using a pulse-acquire 
technique and an adiabatic hyperbolic secant excitation pulse. After acquisition 
of a fully relaxed spectrum at rest (20 averages, TR = 16s, 5 dummy scans, 
2048 sample points), the participants performed 1 isometric plantarflexion at 
85% MVFP for 30 s (five dummy scans, 20 spectra before the exercise for 
saturation correction, TR = 1.5 s and three signal averages per time point, 
leading to a temporal resolution of 4.5 s). After that, participants were allowed 
to recover in the fixed position for 20 min before performing an isometric 
plantarflexion at 70% MVFP for 120 s or until exhaustion (five dummy scans, 
TR = 1.5 s and three signal averages per time point). If the volunteer was not 
able to reach the required force level for a continuous time of more than five 
seconds, the display of the visual feedback was stopped and the subject was 
told to discontinue the contraction so that the recovery period could be 
followed. Recovery spectra were measured after exercise cessation for 324 
(plantarflexion at 85% MVFP) and 264 seconds (plantarflexion at 70% MVFP). 
After both plantarflexion efforts, perceived exertion was rated according to a 
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modified Borg scale from 0 to 10 (Wilson & Jones, 1991a). Two different 
dynamic spectroscopy measurements were chosen to monitor the changes at 
various time-scales and close to the maximal performance (85% and 70% 
MVFP) of the subjects at different pH levels.
Spectral processing. All free-induction decays (FIDs) were zero-filled to 4096
points, line-broadened with 6 Hz and Fourier-transformed into spectra. We 
used tdfdfit software (Slotboom et al., 1998) for fitting the line-shapes and 
integrating the metabolite peak areas. 12 lines were included in the fit model, 
one line each for Pi, monoester, diester, PCr, and a baseline component, and 
	%"
79;9;	"
.ATP. The spectrum was then 
fitted as a sum of basic mathematical model functions (Voigt lines).
Inorganic phosphate (Pi) and phosphocreatine (PCr) concentrations were 
calculating using the PCr/ATP and the Pi/ATP ratios, respectively. To this end, 
a concentration of 8.2 mM was assumed for ATP (Arnold et al., 1984; Kemp & 
Radda, 1994). The saturation factor in the dynamic spectra was determined by 
the ratio of the relaxed spectra to the partially saturated spectra acquired prior 
to the plantarflexion exercise. 
Calculations. Oxidative phosphorylation was quantified based on the PCr 
recovery following the 30 s plantarflexion at 85% MVFP. During the 30 s 
plantarflexion at 85% MVFP muscle pH remained close to 7.0 (Crowther et al., 
2002; Crowther et al., 2003b). We calculated the PCr recovery rate using a 
monoexponential fitting procedure (Iotti 1993), and oxidative capacity (Mox cap)
as the product of the PCr recovery rate constant (kPCr) and the resting PCr 
concentration ([PCr]rest): Mox cap = kPCr · [PCr]rest (Conley et al., 2000).
Intracellular pH-values were calculated from the chemical shift of Pi according 
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to the modified Henderson-Hasselbalch equation by Petroff et al. (Petroff et al., 
1988).
Exclusion criteria. Rigorous quality criteria were applied to the spectra. We 
excluded the spectra acquired under exercise conditions from the analysis if the 
participants’ rating of perceived exertion (Wilson & Jones, 1991b) was below 
7, and the PCr decrease was below 10%. In addition, we excluded spectra if the 
deviation of the exerted force from the target force (85 and 70% MVFP) was > 
5% for > 5s within the duration of the measurement, i.e. when the participant 
was exhausted before the end of the exercise. Altogether the experimental data 
of 5 subjects (1 DIA and 4 CON) were excluded for the 30 s exercise and the 
data of 20 subjects (5 DIA and 15 CON) were omitted for the 120 s exercise.
Skeletal muscle biopsy analyses
Sample preparation. After local anesthesia with 1% lidocaine, we obtained 
percutaneous biopsies from the middle region of the nondominant soleus and 
vastus lateralis muscles, using a ProMag Ultra device and 14 gauge needles 
(Angiotech Pharmaceuticals, Gainesville, FL, USA) as previously described 
(Wälti 2006). After removal, the muscle tissue was immediately mounted in an 
embedding medium (Tissue-Tek, Sakura, Zoeterwoude, The Netherlands), 
snap frozen in isopentane cooled to ?52 @A %	 "/ 	 
subsequently stored at ?0@A	"
A
	5 m sections were cut 
on a microtome at ?, @A   ounted on glass cover slides for further 
histochemical and immunohistochemical analyses.
Fiber size and mitochondrial enzyme activity. We stained the serial cryocut 
cross-sections using the myofibrillar adenosinetriphosphatase (mATPase) 
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method after acid (pH 4.3 and 4.6) and alkali (pH 10.5) preincubation 
according to Guth and Samaha (Guth & Samaha, 1970), with minor
modifications (Müntener 1979). Subsequently, we classified the muscle fibers 
according to their myosin heavy chain (MYH) isoform into MYH-1 and MYH-
2, and measured the muscle fibers' diameter by the lesser fiber diameter-method 
(Dubowitz & M., 1985). We estimated the fiber cross-sectional area (CSA) 
from the lesser diameter. For this purpose, muscle fibers were assumed to be 
circular. For the analysis of oxidative enzyme activity, we incubated 
consecutive sections in media containing cytochrome c oxidase.
Muscle capillarization. We fixed consecutive cryocut sections with acetone for 
10 min at 4°C and exposed them to the monoclonal mouse anti-human CD31 
endothelial cell antibody (DAKO, Carpinteria, Canada, 1:600 dilution), which 
acts as a marker for muscle capillarization. We performed this staining 
procedure using the Vectastain ABC Kit (Vector laboratories, Burlingame, 
Canada) according to the manufacturer’s instructions. For the control samples, 
we replaced the antibody with Tris-buffered saline (TBS) buffer. The capillary-
to-fiber ratio was calculated by dividing the number of CD31-positive cells by 
the number of muscle fibers. 
Quality control. For all fiber analyses, only fibers fully encircled by adjacent 
fibers were evaluated, and measurements were made for at least 50 of each of 
the main fiber types (i.e. MYH-1 and MYH-2). Previous studies investigating 
the skeletal muscle fiber sample size required for a reliable, valid representation 
of an individual's average fiber area and capillary-to-fiber ratio showed that 50 
fiber measurements per individual for type 1 and 2 fibers and capillary contacts 
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are sufficient to characterize type 1 and 2 fiber areas and capillary-to-fiber ratio 
of an individual (McCall et al., 1998; Porter et al., 2002).
Image analysis. Images were captured by an optical widefield microscope 
(Polyvar, Reichert-Jung, Vienna, Austria) with a connected digital camera 
(Leica DFC 420 C, Wetzlar, Germany) under the same microscope objective 
(10×). For all histochemical and immunohistochemical analyses, we used the 
NIH Image J (1.41o, National Institutes of Health, Bethesda, MD, USA) 
software. Arbitrary cytochrome c enzyme activity levels were derived from the 
measured mean optical density pixel values of the muscle fibers normalized to 
the background pixel values on the same section.
Cardiac output and oxygen consumption measurements
We used Innocor™ (Innovision, Odense, Denmark) to determine peak cardiac 
output by inert gas rebreathing and oxygen consumption by breath-by-breath 
ergospirometry during a graded cycling exercise test, as previsously described 
(Fontana et al., 2009). To this end, the participants were equipped with a heart 
rate monitor (S610i, Polar Electro, Kempele, Finland), a facemask (Hans 
Rudolph, Shawnee, KS, USA), an anti-bacterial filter (PALL PF30-S, Pall, East 
Hills, NY, USA), and an arterial oxygen saturation sensor (Innocor™, 
Innovision, Odense, Denmark). Participants rested in the seated position on the 
cycle ergometer for 2 min, after which they started cycling at 50 W. Power was 
increased by 25 W every 2 min until volitional exhaustion, which was defined 
as the point in time at which the participants stopped cycling. On the 50 W 
stage of the baseline test, we determined the individually preferred cycling 
cadence (C 4  -1), which the participants then consistently (± 5 
revolutions·min-1) applied throughout the test. We determined cardiac output at 
118 Chapter 6: 31P MRS: Diabetes Study
rest, 50 W, 75 W, and at peak exercise, i.e. immediately before volitional 
exhaustion. Arterio-venous oxygen difference was calculated by dividing 
oxygen consumption by cardiac output. .
Endurance capacity
On a separate day, we used constant-load cycling exercise tests to assess time 
to exhaustion as an indicator of endurance capacity. After 2 min of rest, the 
participants started pedaling at their individually preferred cycling cadence, as 
determined during the first graded exercise test. Power of the initial warm-up
stage was 40% maximal power of the first graded exercise test. After 1 min, we 
increased power to 60% peak power (for 2 min) and then to 85% maximal 
power. Power at 85% maximal power was sustained until volitional exhaustion, 
which we defined as the point in time, at which the participants stopped 
pedaling or were no longer able to maintain cycling cadence within the required 
limits (70 ± 5 revolutions·min-1). 
Dual-energy X-ray absorptiometry 
Prior to the dual-energy X-ray absorptiometry (DXA) measurement, we 
assessed body mass and body height. Subsequently, we determined waist and 
hip circumference, and calculated the waist-to-hip ratio. These physical 
measurements were performed according Knöpfli et al. 2010. Total body DXA 
measurements were performed with a Lunar iDXA™ (GE Healthcare, 
Madison, WI, USA) according to the manufacturer's specifications. All scans 
were conducted in standard mode (0.13?, +  
 "$

 %

performed using GE encore software version 11.40.004. Total body fat and lean 
mass, % body fat (from tissue), as well as abdominal ("android) and 
gluteofemoral ("gynoid") fat and lean masses were used for subsequent 
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analyses. Android and gynoid regions of interest (ROI) were defined as 
previously described (Knoepfli-Lenzin et al.). Total skeletal muscle mass was 
calculated from appendicular lean masses according to Kim et al.(Kim et al., 
2002). 
Blood analyses
Venous blood samples were collected in EDTA, separated, and stored at ?
°C before being assayed. Plasma glucose concentrations were determined by an 
automated hexokinase method (HK Unit-Kit III, Roche, Basel, Switzerland), 
and serum insulin concentrations were determined by radioimmunoassay 
(Insulin ct-kit, Cisbio Bioassays, Bagnols-sur-Cèze, France). HbA1c was 
immunochemically measured with the DXC 2000 device (Bayer, Leverkusen, 
Germany). High-sensitivity C-reactive protein (hsCRP) was assessed with the 
Immulite 2500 kit (Siemens, Los Angeles, CA, USA), triglyceride, high-
density lipoprotein (HDL), and cholesterol were analyzed using commercial 
tests from Roche (Basel, Switzerland). For CON, a standard oral glucose 
tolerance test (OGTT) was performed in the morning after an overnight (12 h) 
fast. The participants ingested 75 g of glucose in 0.3 l water. Venous blood 
samples were drawn 2 times just before, and at 30, 60, 90, and 120 min after 
ingestion of glucose for determining plasma glucose and serum insulin 
concentrations. Insulin sensitivity was estimated by the homeostasis model 
assessment (HOMA) and calculated as HOMA = [fasting insulin (U·ml-1] x 
[fasting glucose (mmol·l-1)] / 22.5 (Matthews et al., 1985).
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Statistical analyses
Data are presented as mean and standard deviation (SD). Group differences 
between DIA and CON were tested for statistical significance by t-tests for 
independent samples, and equality of variances was checked using Levene’s 
test. The level of significance was set to P < 0.05. For all statistical analyses, 
SPSS 16.0 statistical software (SPSS, Chicago, IL, USA) was used.
6.3 Results 
Skeletal muscle energetics and oxidative capacity
Resting muscle. [PCr] and at rest were not different between DIA (N=9) and 
CON (N=29) (38.2 [3.7] vs. 37.6 [3.4]) and [Pi] remained equally unchanged
(4.67 [0.75] vs. 4.87 [0.75]). Also, the mean pH value at rest was the same for 
both, DIA and CON (7.03[0.01] vs. 7.03 [0.01]) shows a representative fit of a 
spectrum acquired under full relaxation (Figure 21). 
Figure 21 Representative fit of a spectrum fully relaxed spectrum. The 
magnitude spectrum is shown in blue, and the fit is displayed in red.
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30 s isometric plantarflexion. The pH curves for DIA and CON displayed 
concordant behavior with similar standard deviations (Figure 23a). No 
difference was found between DIA (N=8) and CON (N=25) for neither kPCr
(0.032 [0.005] vs. 0.0333 [0.005] s-1) nor Mox cap (1.23 [0.30] vs. 1.14 [0.21]
mM·s-1). Consequently, PCr recovery was similar between the 2 groups (Figure 
22a). 
120 s isometric plantarflexion. Only 4 DIA and 14 CON subjects were able to 
maintain the desired force for the entire course of the exercise (see Research 
Design and Methods) and were subsequently considered for the analysis. While
the spectra of the pH time courses (Figure 23b) for DIA were in very good 
agreement with those of CON (pH at the end of exercise: 6.79 [0.09] vs. 6.78
[0.12]), [PCr] at the end of exercise appeared to be lower in DIA than CON, but 
the apparent difference was not statistically significant (9.5 [2.1] vs. 12.15
[5.07] mM, Figure 22b). Also, the recovery constants kPCr did not show any 
difference (0.026 [0.004] vs. 0.024 [0.006] s-1).
a b
Figure 22 [PCR] timelines for DIA (blue) and CON (red) subjects. The 30s 
exercise is displayed on the left. On the right, the 120s exercise is shown.
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A                                                                      B
Figure 23 pH curves for the 30s (left) and 120s (right) spectra for the DIA 
(blue) and CON (red) groups.
Skeletal muscle capillarization, phenotype, and oxidative enzyme activity
No differences were found in capillary-to-fiber ratio between DIA and CON in 
soleus (N=5 for DIA and N=15 for CON) (1.59 [0.29] vs. 1.80 [0.35]) and 
vastus lateralis (1.50 [0.08] vs. 1.52 [0.20]) muscles. Furthermore, the muscle
phenotypes of soleus (MYC I: 82.3 [9.0] vs. 81.5 [9.2] %) and vastus lateralis 
(MYC I: 61.8 [5.5] vs. 61.4 [9.1] %) muscles, as well as cytochrome c oxidase 
activity (N=6 for DIA and N=11 for CON) (Figure 24) were similar between 
DIA and CON. 
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Figure 24 Cytochrome c oxidase activity of soleus (SOL) and vastus 
lateralis (VL) muscles are shown of 6 patients with type 1 diabetes (DIA, 
white bars) and 11 women from the control group (CON, black bars) (P >
0.05). Bars and error bars represent mean value and standard deviations, 
respectively. AU, arbitrary units; MYC I, myosin heavy chain I; MYC II, 
myosin heavy chain II.
Skeletal muscle fiber size
The mean fiber diameter of the soleus muscle was not different between DIA
(N=6) and CON (N=14) (MYC I: 60.8 [12.4] vs. 55.9 [7.2] ). In contrary, 
the mean fiber diameter of vastus lateralis was higher in DIA (N=6 for MHC I 
and MHCII) compared to CON (N=16 for MHC I and N=14 for MHCII) (MYC
I: 59.1 [8.0] vs. 53.6 [7.7] P < 0.05; MYC II: 63.1 [5.7] 
,61D,0E
P < 0.01).
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Oxygen consumption, cardiac output, and arterio-venous oxygen 
difference
Submaximal and maximal values of oxygen consumption, cardiac output, and 
arterio-venous oxygen difference during the incremental exercise test did not 
differ between DIA (N=9) and CON (N=29) (Figure 25). Additionally, dividing 
delta cardiac output (peak minus rest values) by delta oxygen consumption 
reveals, that dynamic changes during the incremental exercise test were similar 
between the 2 groups (4.08 [0.62] vs. 4.12 [0.94]). Moreover, maximal oxygen 
consumption (32 [7] vs. 35 [5] mlmin-1kg-1) and peak cardiac output (180 [40] 
vs. 198 [26] mlmin-1kg-1) were both not statistically significant different 
between DIA and CON.
Exercise performance and endurance capacity
In agreement with a lack of metabolic disparity, no differences in maximal 
power output (incremental exercise test: 171 [25] vs. 163 [26] W) as well as in 
endurance capacity (time to exhaustion: 471 [119] vs. 532 [212] s) were found 
between DIA (N=9) and CON (N=29). 
Body composition
Lean mass, % body fat, and waist to hip ratio were not different between DIA 
(N=9) and CON (N=29), while body mass, body fat mass, and body mass index 
were higher in DIA than in CON (Table 7 and Table 8). The calculated skeletal 
muscle mass was higher in DIA than in CON and reached almost statistical 
significance. 
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Figure 25 Haemodynamic kinetics during the incremental exercise test. 
Oxygen consumption (VO2max), cardiac output (Q), and arterio-venous 
oxygen difference (avDO2) in patients with type 1 diabetes (DIA, white bars) 
and healthy controls (CON, black bars) are shown (P > 0.05). Bars and 
error bars represent mean values and standard deviations, respectively.
6.4 Discussion
In the present study, we have demonstrated that skeletal muscle mitochondrial 
oxidative function, muscle capillarization, muscle fiber metabolic phenotype, 
oxygen consumption, cardiac output, arterio-venous oxygen difference, and 
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endurance capacity do not differ between women with well-controlled type 1 
diabetes and healthy controls. These findings lend further credence to the 
emerging notion that diabetes might not be associated with impaired 
mitochondrial and cardiorespiratory function, as well as endurance capacity.
The mitochondrial respiratory function was investigated with an in vivo
assessment by means of 31P-MRS. The rate of PCr resynthesis after exercise 
(Figure 22), which depends on mitochondrial respiration (Arnold et al., 1984; 
Chance et al., 1986; Iotti et al., 1993), is not statistically significant different 
between patients with type 1 diabetes and control subjects. Furthermore, the pH 
was similar at rest and after an exercise bout performed until exhaustion 
(Figure 23). Contrary to our findings, Crowther et al. (Crowther et al., 2003a)
presented significant differences in the Mox cap and in the pH course of men 
with type 1 diabetes and healthy controls. However, the subjects in this study 
were obese and suffering from different side effects. Moreover, the discrepancy 
in the pH course may be due to the fact that in our study, the subjects were all 
pushing at the same % of their MVFP, while the course of force values during 
the exercise in the study conducted by Crowther et al. (Crowther et al., 2003a)
differs between patients with type 1 diabetes and healthy controls. Hence, there 
may have been a stronger drop in pH due to a stronger exhibited force rather 
than a change in metabolism between patients with diabetes and healthy 
controls. The PCr decline is similar between patients with type 1 diabetes and 
healthy controls in (Crowther et al., 2003a), however, after about 30 s the ATP
supply trough glycolysis reaches a maximum and the hydrolysis of ATP 
generated this way contributes to a further acidification of muscle tissue. A 
stronger exerted force therefore could lead to a stronger decrease in pH. Our 
observation of a normal mitochondrial respiratory function in patients with type 
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1 diabetes assessed by 31P-MRS is confirmed by skeletal muscle single-fiber 
analysis of cytochrome c oxidase activity (Figure 24). In line with these results, 
another recent study also did not find any differences in oxidative enzyme 
activity levels measuring succinate dehydrogenase in young subjects with type 
1 diabetes and low habitual physical activity levels (Fritzsche et al., 2008). In 
contrast, He et al. (He et al., 2001) showed that skeletal muscle oxidative 
enzyme activity in obese and patients with type 2 diabetes are lower compared 
to lean healthy subjects. Considering that also the subjects from the group with 
type 2 diabetes were obese, it is not proven that the reduced oxidative enzyme 
activity results from diabetes itself or rather from obesity. 
As we have shown, Mox cap of patients with type 1 diabetes is not impaired by 
means of mitochondrial enzymatic changes. Mitochondrial oxidative function 
stands for oxidative phosphorylation, e.g. the formation of ATP from ADP and 
Pi in association with the transfer of electrons from fuel molecules to 
coenzymes and finally to oxygen. Therefore, the delivery of oxygen from the 
ambient air to the skeletal muscle is another limiting factor of the oxidative 
function. It is believed that in healthy humans, high oxygen consumption 
primarily depends on oxygen delivery to the exercising muscles (Bassett & 
Howley, 2000; Saltin & Calbet, 2006). The capacity for oxygen delivery can be 
estimated by 4 main factors. First, the measurement of oxygen consumption 
serves as an indicator of whole-body oxygen consumption. Second, cardiac 
output is the volume of blood being pumped by the heart ventricle, and the 
main factor limiting maximal oxygen uptake (Bassett & Howley, 2000). Third, 
the abundance of skeletal muscle capillaries determines the capacity for oxygen 
flux from blood to the muscle fiber. Finally, the arterio-venous oxygen 
difference represents the extent to which oxygen is removed from the arterial 
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blood. Whereas it is believed that oxygen consumption and exercise 
performance is reduced in type 2 diabetes (Regensteiner et al., 1998; Baldi et 
al., 2003), it is not clear if it is also the case in type 1 diabetes (Veves et al., 
1997; Nadeau et al., 2009). However, our data clearly show that oxygen 
consumption (Figure 25), the exercise performance assessed by peak power 
during the incremental exercise test, as well as the endurance capacity are 
similar in patients with type 1 diabetes compared to healthy controls. These 
data are underlined by the cardiovascular measurements of central (cardiac 
output) and peripheral (arterio-venous oxygen difference, skeletal muscle 
capillarization) factors (Figure 25), which figure to the oxidative capacity. 
These consistent findings confirm and emphasize, that the whole oxidative 
system is not altered in type 1 diabetes. To our knowledge, this is the first 
extensive study that has investigated the whole oxidative system, i.e. the 
cellular, energetic, and functional markers of oxidative capacity in patients with 
type 1 diabetes and healthy controls.
The body composition (Table 7) and the state of health (Table 8) of the subjects 
tested in this study were similar, expect of the existence of type 1 diabetes in 
the DIA group (no diabetic complications or cardiovascular diseases). This is of 
important note, since it is delicate to interpret a dependence of a specific 
condition to an adaptational effect when confounding variables cannot be 
minimized. Nevertheless, due to the fact that also visceral fat mass is central in 
type 1 diabetes (Wilkin, 2001), the subjects with diabetes in this study differ in 
both body mass and fat content when compared to the control group (Table 7). 
However, the average body mass index is just in the normal range (18.5-25 
kgm-2). This presents a difference to many studies conducted in patients with 
type 1 and type 2 diabetes, where the average subject was overweight or obese 
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with reported body mass index values well above 25 kgm-2 (He et al., 2001; 
Crowther et al., 2003a; Mootha et al., 2003b). Taken together, we could 
minimize the confounding variables and accomplish this study with 2 
homogenous study groups.
Typically, insulin resistance is related to type 2 diabetes. However, it has been 
claimed that the etiology and conditions of type 1 and type 2 diabetes are 
blurring and overlapping (Wilkin, 2001; Donath & Halban, 2004). There is 
elevating evidence that a decreased 	-cell function is the hallmark of both type 
1 and type 2 diabetes (Donath & Halban, 2004) whereas insulin resistance is 
associated with visceral fat mass meaning that visceral weight gain is central in 
both types of diabetes (Wilkin, 2001). In line with these assumptions it has 
been shown that also patients with type 1 diabetes display decreased insulin 
sensitivity compared to healthy controls (DeFronzo et al., 1982a; DeFronzo et 
al., 1982b; Greenbaum, 2002; Dabelea et al., 2003; Nadeau et al., 2009). 
Therefore, based on our findings, we suggest that insulin resistance is not a 
consequence of a reduced oxidative function.
In summary, we present evidence that women with well-controlled type 1 
diabetes exhibit similar skeletal muscle mitochondrial oxidative function, 
muscle capillarization, muscle fiber metabolic phenotype, and cardiorespiratory 
capacity as their age- and activity-matched controls, and therefore, supports the 
hypothesis that insulin resistance is not the result of a decreased mitochondrial 
function.
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The thesis aims at developing hardware and software to enable the reliable 
quantification of metabolite concentrations and metabolic parameters in human 
subjects at rest and during exercise. This goal is achieved by pursuing two 
different approaches. One approach focuses on the development of a method 
for the quantification of metabolite concentrations based on the ERETIC 
method. The second approach includes the design and implementation of an 
ergometer setup that enables the reliable standardization of exerted muscle 
force during dynamic MRS scans.
The quantification method ERETIC (Electric REference to access In vivo 
Concentrations, (Barantin, 1997)) has been successfully developed into a 
method that can now be applied for the quantification of metabolite 
concentrations in vivo. Several hurdles have been overcome to achieve this 
goal. The initial ERETIC setup was based on a sending antenna that was placed 
anywhere in the room. The amplitude of the calibration signal is then 
influenced by any objects in the vicinity of the antenna, such as the patient 
itself. To achieve a reliable scaling of the ERETIC signal amplitude with the 
coil load and the receiver gain, the signal had to be inductively coupled into the 
receive coil. In addition, an optic transmission of the signal was needed so that 
parasitic coupling with other cables or senders in the room could be avoided. In 
the end, a software interface was programmed so that the phase, frequency, 
amplitude and decay constant of the signal can be freely changed to adjust the 
signal to the free induction decay (FID) of the spins that are being measured. 
This way, spectra of metabolites containing different nuclei can be quantified 
and the spectra can subsequently be processed and quantified using standard 
software. Main advantages of this electric reference signal are the possibility to 
acquire the spectrum and the reference in a single scan (no additional 
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measurements are required), and its applicability to the measurement of spectra 
at any frequency (i.e. 13C, 1H, 31P). 
In principle, the advanced ERETIC setup may be used in combination with any 
coil, such as coils for different nuclei, multi-channel coil arrays, and surface 
coils. However, further hardware modifications are needed to enable a reliable 
quantification with surface coils and multi-channel coils due to their different 
B1 homogeneity and reception sensitivity compared to single channel volume 
coils.
Promising future applications of the advanced ERETIC method include 
physiological and clinical studies in tissues where no internal reference 
metabolites are available for quantification, e.g. without the knowledge of the 
water content. Also, studies can be conducted for other nuclei, such as 13C. The 
software can be readily adjusted to enable quantification of metabolite 
concentrations using other spectroscopy techniques than single voxel 
spectroscopy, such as chemical shift imaging (CSI). There, the phase of the 
ERETIC signal needs to be changed for each phase encoding step so that the 
reference signal appears in a single voxel of the spectroscopic grid only. 
Furthermore, one could think of similar adaptations that would enable the use 
of the ERETIC reference signal for the quantification of image data (Franconi
et al., 2002). 
Dynamic spectroscopy measurements during exercise have been widely used in 
physiological and medical studies of muscle metabolism. In order to 
standardize these measurements, the used ergometers have to be able to 
quantify forces and a visual feedback of the momentary contraction for the 
subject is needed. The ergometer setup that has been developed and 
implemented during the course of this thesis takes these requirements into 
account and therefore enables the acquisition of well-standardized MRS scans 
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and the exploration of basic muscle physiology in vivo. For the development of 
the ergometer, special attention has been paid to the choice of the involved 
materials since they had to be MR-compatible. Moreover, a visual force 
feedback for the subjects was implemented. The setup was subsequently 
successfully applied in two physiological studies, which aimed at the 
examination of muscle metabolism during isometric muscle contractions in 
diabetes type 1 patients and subjects that were trained using an ischemic 
training paradigm. 
In combination with biochemical methods and analysis of muscle biopsies, the 
presented ergometer setup is a promising way of obtaining information about 
the muscle metabolism. In the future, the ergometer setup could be extended to 
allow measurements during dynamic contractions of the muscle.
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